Search Results For:

				GHIAA2019\MapguideSearch Object
(
    [search_parameters] => Array
        (
            [agreement-type] => Array
                (
                    [0] => license-agreement
                )

            [issue] => Array
                (
                    [0] => roles-responsibilities
                )

        )

    [filters] => Array
        (
            [agreement] => Array
                (
                    [agreement-type] => Array
                        (
                            [0] => license-agreement
                        )

                )

            [provision] => Array
                (
                    [issue] => Array
                        (
                            [0] => roles-responsibilities
                        )

                )

        )

    [child_filters] => Array
        (
        )

    [agreement_args] => Array
        (
            [post_type] => agreement
            [posts_per_page] => -1
            [tax_query] => Array
                (
                    [0] => Array
                        (
                            [taxonomy] => agreement-type
                            [field] => slug
                            [terms] => Array
                                (
                                    [0] => license-agreement
                                )

                        )

                )

        )

    [provision_args] => Array
        (
            [post_type] => provision_document
            [posts_per_page] => -1
            [tax_query] => Array
                (
                    [0] => Array
                        (
                            [taxonomy] => issue
                            [field] => slug
                            [terms] => Array
                                (
                                    [0] => roles-responsibilities
                                )

                        )

                )

            [meta_query] => Array
                (
                    [relation] => OR
                    [0] => Array
                        (
                            [key] => agreement
                            [value] => "1084"
                            [compare] => LIKE
                        )

                    [1] => Array
                        (
                            [key] => agreement
                            [value] => "1087"
                            [compare] => LIKE
                        )

                    [2] => Array
                        (
                            [key] => agreement
                            [value] => "12797"
                            [compare] => LIKE
                        )

                    [3] => Array
                        (
                            [key] => agreement
                            [value] => "1088"
                            [compare] => LIKE
                        )

                    [4] => Array
                        (
                            [key] => agreement
                            [value] => "1090"
                            [compare] => LIKE
                        )

                    [5] => Array
                        (
                            [key] => agreement
                            [value] => "1039"
                            [compare] => LIKE
                        )

                    [6] => Array
                        (
                            [key] => agreement
                            [value] => "4467"
                            [compare] => LIKE
                        )

                    [7] => Array
                        (
                            [key] => agreement
                            [value] => "4794"
                            [compare] => LIKE
                        )

                    [8] => Array
                        (
                            [key] => agreement
                            [value] => "11245"
                            [compare] => LIKE
                        )

                    [9] => Array
                        (
                            [key] => agreement
                            [value] => "3817"
                            [compare] => LIKE
                        )

                    [10] => Array
                        (
                            [key] => agreement
                            [value] => "9858"
                            [compare] => LIKE
                        )

                    [11] => Array
                        (
                            [key] => agreement
                            [value] => "9849"
                            [compare] => LIKE
                        )

                    [12] => Array
                        (
                            [key] => agreement
                            [value] => "4832"
                            [compare] => LIKE
                        )

                    [13] => Array
                        (
                            [key] => agreement
                            [value] => "13124"
                            [compare] => LIKE
                        )

                    [14] => Array
                        (
                            [key] => agreement
                            [value] => "11464"
                            [compare] => LIKE
                        )

                    [15] => Array
                        (
                            [key] => agreement
                            [value] => "3373"
                            [compare] => LIKE
                        )

                    [16] => Array
                        (
                            [key] => agreement
                            [value] => "1083"
                            [compare] => LIKE
                        )

                    [17] => Array
                        (
                            [key] => agreement
                            [value] => "1099"
                            [compare] => LIKE
                        )

                    [18] => Array
                        (
                            [key] => agreement
                            [value] => "12137"
                            [compare] => LIKE
                        )

                    [19] => Array
                        (
                            [key] => agreement
                            [value] => "12820"
                            [compare] => LIKE
                        )

                    [20] => Array
                        (
                            [key] => agreement
                            [value] => "12903"
                            [compare] => LIKE
                        )

                    [21] => Array
                        (
                            [key] => agreement
                            [value] => "11343"
                            [compare] => LIKE
                        )

                    [22] => Array
                        (
                            [key] => agreement
                            [value] => "12775"
                            [compare] => LIKE
                        )

                    [23] => Array
                        (
                            [key] => agreement
                            [value] => "1103"
                            [compare] => LIKE
                        )

                    [24] => Array
                        (
                            [key] => agreement
                            [value] => "3888"
                            [compare] => LIKE
                        )

                    [25] => Array
                        (
                            [key] => agreement
                            [value] => "12922"
                            [compare] => LIKE
                        )

                    [26] => Array
                        (
                            [key] => agreement
                            [value] => "12092"
                            [compare] => LIKE
                        )

                    [27] => Array
                        (
                            [key] => agreement
                            [value] => "11785"
                            [compare] => LIKE
                        )

                    [28] => Array
                        (
                            [key] => agreement
                            [value] => "11600"
                            [compare] => LIKE
                        )

                    [29] => Array
                        (
                            [key] => agreement
                            [value] => "11722"
                            [compare] => LIKE
                        )

                    [30] => Array
                        (
                            [key] => agreement
                            [value] => "3404"
                            [compare] => LIKE
                        )

                    [31] => Array
                        (
                            [key] => agreement
                            [value] => "1092"
                            [compare] => LIKE
                        )

                    [32] => Array
                        (
                            [key] => agreement
                            [value] => "11094"
                            [compare] => LIKE
                        )

                    [33] => Array
                        (
                            [key] => agreement
                            [value] => "5110"
                            [compare] => LIKE
                        )

                    [34] => Array
                        (
                            [key] => agreement
                            [value] => "12012"
                            [compare] => LIKE
                        )

                    [35] => Array
                        (
                            [key] => agreement
                            [value] => "3794"
                            [compare] => LIKE
                        )

                    [36] => Array
                        (
                            [key] => agreement
                            [value] => "4026"
                            [compare] => LIKE
                        )

                    [37] => Array
                        (
                            [key] => agreement
                            [value] => "1091"
                            [compare] => LIKE
                        )

                    [38] => Array
                        (
                            [key] => agreement
                            [value] => "11063"
                            [compare] => LIKE
                        )

                    [39] => Array
                        (
                            [key] => agreement
                            [value] => "11038"
                            [compare] => LIKE
                        )

                    [40] => Array
                        (
                            [key] => agreement
                            [value] => "11099"
                            [compare] => LIKE
                        )

                    [41] => Array
                        (
                            [key] => agreement
                            [value] => "11079"
                            [compare] => LIKE
                        )

                    [42] => Array
                        (
                            [key] => agreement
                            [value] => "11672"
                            [compare] => LIKE
                        )

                    [43] => Array
                        (
                            [key] => agreement
                            [value] => "12846"
                            [compare] => LIKE
                        )

                    [44] => Array
                        (
                            [key] => agreement
                            [value] => "12992"
                            [compare] => LIKE
                        )

                    [45] => Array
                        (
                            [key] => agreement
                            [value] => "2420"
                            [compare] => LIKE
                        )

                    [46] => Array
                        (
                            [key] => agreement
                            [value] => "5267"
                            [compare] => LIKE
                        )

                    [47] => Array
                        (
                            [key] => agreement
                            [value] => "12108"
                            [compare] => LIKE
                        )

                    [48] => Array
                        (
                            [key] => agreement
                            [value] => "11543"
                            [compare] => LIKE
                        )

                    [49] => Array
                        (
                            [key] => agreement
                            [value] => "12678"
                            [compare] => LIKE
                        )

                    [50] => Array
                        (
                            [key] => agreement
                            [value] => "11568"
                            [compare] => LIKE
                        )

                    [51] => Array
                        (
                            [key] => agreement
                            [value] => "11325"
                            [compare] => LIKE
                        )

                    [52] => Array
                        (
                            [key] => agreement
                            [value] => "1086"
                            [compare] => LIKE
                        )

                    [53] => Array
                        (
                            [key] => agreement
                            [value] => "13069"
                            [compare] => LIKE
                        )

                    [54] => Array
                        (
                            [key] => agreement
                            [value] => "4070"
                            [compare] => LIKE
                        )

                    [55] => Array
                        (
                            [key] => agreement
                            [value] => "12753"
                            [compare] => LIKE
                        )

                    [56] => Array
                        (
                            [key] => agreement
                            [value] => "1089"
                            [compare] => LIKE
                        )

                    [57] => Array
                        (
                            [key] => agreement
                            [value] => "12707"
                            [compare] => LIKE
                        )

                    [58] => Array
                        (
                            [key] => agreement
                            [value] => "12731"
                            [compare] => LIKE
                        )

                    [59] => Array
                        (
                            [key] => agreement
                            [value] => "9033"
                            [compare] => LIKE
                        )

                )

        )

    [text_agreement_args] => 
    [text_provision_args] => 
    [agreement_ids] => Array
        (
            [0] => 1084
            [1] => 1087
            [2] => 12797
            [3] => 1088
            [4] => 1090
            [5] => 1039
            [6] => 4467
            [7] => 4794
            [8] => 11245
            [9] => 3817
            [10] => 9858
            [11] => 9849
            [12] => 4832
            [13] => 13124
            [14] => 11464
            [15] => 3373
            [16] => 1083
            [17] => 1099
            [18] => 12137
            [19] => 12820
            [20] => 12903
            [21] => 11343
            [22] => 12775
            [23] => 1103
            [24] => 3888
            [25] => 12922
            [26] => 12092
            [27] => 11785
            [28] => 11600
            [29] => 11722
            [30] => 3404
            [31] => 1092
            [32] => 11094
            [33] => 5110
            [34] => 12012
            [35] => 3794
            [36] => 4026
            [37] => 1091
            [38] => 11063
            [39] => 11038
            [40] => 11099
            [41] => 11079
            [42] => 11672
            [43] => 12846
            [44] => 12992
            [45] => 2420
            [46] => 5267
            [47] => 12108
            [48] => 11543
            [49] => 12678
            [50] => 11568
            [51] => 11325
            [52] => 1086
            [53] => 13069
            [54] => 4070
            [55] => 12753
            [56] => 1089
            [57] => 12707
            [58] => 12731
            [59] => 9033
        )

    [agreement_q_rslts] => WP_Query Object
        (
            [query] => Array
                (
                    [post_type] => agreement
                    [posts_per_page] => -1
                    [tax_query] => Array
                        (
                            [0] => Array
                                (
                                    [taxonomy] => agreement-type
                                    [field] => slug
                                    [terms] => Array
                                        (
                                            [0] => license-agreement
                                        )

                                )

                        )

                )

            [query_vars] => Array
                (
                    [post_type] => agreement
                    [posts_per_page] => -1
                    [tax_query] => Array
                        (
                            [0] => Array
                                (
                                    [taxonomy] => agreement-type
                                    [field] => slug
                                    [terms] => Array
                                        (
                                            [0] => license-agreement
                                        )

                                )

                        )

                    [error] => 
                    [m] => 
                    [p] => 0
                    [post_parent] => 
                    [subpost] => 
                    [subpost_id] => 
                    [attachment] => 
                    [attachment_id] => 0
                    [name] => 
                    [pagename] => 
                    [page_id] => 0
                    [second] => 
                    [minute] => 
                    [hour] => 
                    [day] => 0
                    [monthnum] => 0
                    [year] => 0
                    [w] => 0
                    [category_name] => 
                    [tag] => 
                    [cat] => 
                    [tag_id] => 
                    [author] => 
                    [author_name] => 
                    [feed] => 
                    [tb] => 
                    [paged] => 0
                    [meta_key] => 
                    [meta_value] => 
                    [preview] => 
                    [s] => 
                    [sentence] => 
                    [title] => 
                    [fields] => all
                    [menu_order] => 
                    [embed] => 
                    [category__in] => Array
                        (
                        )

                    [category__not_in] => Array
                        (
                        )

                    [category__and] => Array
                        (
                        )

                    [post__in] => Array
                        (
                        )

                    [post__not_in] => Array
                        (
                        )

                    [post_name__in] => Array
                        (
                        )

                    [tag__in] => Array
                        (
                        )

                    [tag__not_in] => Array
                        (
                        )

                    [tag__and] => Array
                        (
                        )

                    [tag_slug__in] => Array
                        (
                        )

                    [tag_slug__and] => Array
                        (
                        )

                    [post_parent__in] => Array
                        (
                        )

                    [post_parent__not_in] => Array
                        (
                        )

                    [author__in] => Array
                        (
                        )

                    [author__not_in] => Array
                        (
                        )

                    [search_columns] => Array
                        (
                        )

                    [orderby] => title
                    [order] => ASC
                    [ignore_sticky_posts] => 
                    [suppress_filters] => 
                    [cache_results] => 1
                    [update_post_term_cache] => 1
                    [update_menu_item_cache] => 
                    [lazy_load_term_meta] => 1
                    [update_post_meta_cache] => 1
                    [nopaging] => 1
                    [comments_per_page] => 50
                    [no_found_rows] => 
                    [taxonomy] => agreement-type
                    [term] => license-agreement
                )

            [tax_query] => WP_Tax_Query Object
                (
                    [queries] => Array
                        (
                            [0] => Array
                                (
                                    [taxonomy] => agreement-type
                                    [terms] => Array
                                        (
                                            [0] => license-agreement
                                        )

                                    [field] => slug
                                    [operator] => IN
                                    [include_children] => 1
                                )

                        )

                    [relation] => AND
                    [table_aliases:protected] => Array
                        (
                            [0] => wpry_term_relationships
                        )

                    [queried_terms] => Array
                        (
                            [agreement-type] => Array
                                (
                                    [terms] => Array
                                        (
                                            [0] => license-agreement
                                        )

                                    [field] => slug
                                )

                        )

                    [primary_table] => wpry_posts
                    [primary_id_column] => ID
                )

            [meta_query] => WP_Meta_Query Object
                (
                    [queries] => Array
                        (
                        )

                    [relation] => 
                    [meta_table] => 
                    [meta_id_column] => 
                    [primary_table] => 
                    [primary_id_column] => 
                    [table_aliases:protected] => Array
                        (
                        )

                    [clauses:protected] => Array
                        (
                        )

                    [has_or_relation:protected] => 
                )

            [date_query] => 
            [request] => SELECT   wpry_posts.*
					 FROM wpry_posts  LEFT JOIN wpry_term_relationships ON (wpry_posts.ID = wpry_term_relationships.object_id)
					 WHERE 1=1  AND ( 
  wpry_term_relationships.term_taxonomy_id IN (284)
) AND ((wpry_posts.post_type = 'agreement' AND (wpry_posts.post_status = 'publish' OR wpry_posts.post_status = 'acf-disabled')))
					 GROUP BY wpry_posts.ID
					 ORDER BY wpry_posts.post_title ASC
					 
            [posts] => Array
                (
                    [0] => WP_Post Object
                        (
                            [ID] => 1084
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:23:34
                            [post_date_gmt] => 2020-05-21 20:23:34
                            [post_content] => 
                            [post_title] => AbbVie - MPP, HIV Antiretroviral (lopinavir, ritonavir - LPV/r) Pediatric License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-abbvie-sublicense-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-06 13:36:22
                            [post_modified_gmt] => 2024-09-06 13:36:22
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1084
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [1] => WP_Post Object
                        (
                            [ID] => 1087
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:27:18
                            [post_date_gmt] => 2020-05-21 20:27:18
                            [post_content] => 
                            [post_title] => AbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir - LPV/r) License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-abbvie-license-agreement-lpv-r
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-04 12:49:22
                            [post_modified_gmt] => 2024-09-04 12:49:22
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1087
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [2] => WP_Post Object
                        (
                            [ID] => 12797
                            [post_author] => 5
                            [post_date] => 2025-06-26 08:30:26
                            [post_date_gmt] => 2025-06-26 08:30:26
                            [post_content] => 
                            [post_title] => Atreca - Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => atreca-gates-medical-research-institute-malaria-monoclonal-antibodies-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-06-26 08:36:04
                            [post_modified_gmt] => 2025-06-26 08:36:04
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12797
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [3] => WP_Post Object
                        (
                            [ID] => 1088
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:28:31
                            [post_date_gmt] => 2020-05-21 20:28:31
                            [post_content] => 
                            [post_title] => BMS - MPP, Hepatitis C Antiviral (daclatasvir - DAC) License & Tech Transfer Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-bms-aurobindo-sublicense-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-05 08:42:35
                            [post_modified_gmt] => 2024-09-05 08:42:35
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1088
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [4] => WP_Post Object
                        (
                            [ID] => 1090
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:31:01
                            [post_date_gmt] => 2020-05-21 20:31:01
                            [post_content] => 
                            [post_title] => BMS - MPP, HIV Antiretroviral (atazanavir - ATV) License and Technology Transfer Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-bms-sublicense-tech-transfer-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-05 12:40:32
                            [post_modified_gmt] => 2024-09-05 12:40:32
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1090
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [5] => WP_Post Object
                        (
                            [ID] => 1039
                            [post_author] => 6
                            [post_date] => 2020-05-20 21:10:05
                            [post_date_gmt] => 2020-05-20 21:10:05
                            [post_content] => 
                            [post_title] => Boston University Startup Exclusive License Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => boston-university-startup-exclusive-license
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-07-16 14:22:25
                            [post_modified_gmt] => 2024-07-16 14:22:25
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1039
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [6] => WP_Post Object
                        (
                            [ID] => 4467
                            [post_author] => 5
                            [post_date] => 2022-03-17 10:56:00
                            [post_date_gmt] => 2022-03-17 10:56:00
                            [post_content] => 
                            [post_title] => Cellscript - BioNTech mRNA Technology Patent Sublicense
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => cellscript-biontech-mrna-technology-patent-sublicense
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-03-17 10:56:00
                            [post_modified_gmt] => 2022-03-17 10:56:00
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=4467
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [7] => WP_Post Object
                        (
                            [ID] => 4794
                            [post_author] => 5
                            [post_date] => 2022-05-23 13:54:39
                            [post_date_gmt] => 2022-05-23 13:54:39
                            [post_content] => 
                            [post_title] => CSIC - MPP (C-TAP), COVID-19 Diagnostic, Patent & Material License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => csic-mpp-covid-19-antibody-diagnostic-patent-material-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-18 11:53:50
                            [post_modified_gmt] => 2023-09-18 11:53:50
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=4794
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [8] => WP_Post Object
                        (
                            [ID] => 11245
                            [post_author] => 5
                            [post_date] => 2023-09-18 08:29:10
                            [post_date_gmt] => 2023-09-18 08:29:10
                            [post_content] => 
                            [post_title] => CSIC - MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => csic-mpp-c-tap-covid-19-vaccine-patent-and-material-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-18 08:29:10
                            [post_modified_gmt] => 2023-09-18 08:29:10
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11245
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [9] => WP_Post Object
                        (
                            [ID] => 3817
                            [post_author] => 6
                            [post_date] => 2021-09-15 10:46:18
                            [post_date_gmt] => 2021-09-15 10:46:18
                            [post_content] => 
                            [post_title] => CureVac - GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-and-gsk-collaboration-and-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:16:37
                            [post_modified_gmt] => 2022-10-11 12:16:37
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=3817
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [10] => WP_Post Object
                        (
                            [ID] => 9858
                            [post_author] => 5
                            [post_date] => 2023-04-14 11:42:47
                            [post_date_gmt] => 2023-04-14 11:42:47
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-07-16 14:23:08
                            [post_modified_gmt] => 2024-07-16 14:23:08
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=9858
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [11] => WP_Post Object
                        (
                            [ID] => 9849
                            [post_author] => 5
                            [post_date] => 2023-04-14 11:41:02
                            [post_date_gmt] => 2023-04-14 11:41:02
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-07-16 14:23:24
                            [post_modified_gmt] => 2024-07-16 14:23:24
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=9849
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [12] => WP_Post Object
                        (
                            [ID] => 4832
                            [post_author] => 5
                            [post_date] => 2022-05-27 13:18:02
                            [post_date_gmt] => 2022-05-27 13:18:02
                            [post_content] => 
                            [post_title] => Elkurt - Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => elkurt-ocean-biomedical-malaria-vaccine-exclusive-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-05-27 13:18:02
                            [post_modified_gmt] => 2022-05-27 13:18:02
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=4832
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [13] => WP_Post Object
                        (
                            [ID] => 13124
                            [post_author] => 5
                            [post_date] => 2025-09-25 10:01:46
                            [post_date_gmt] => 2025-09-25 10:01:46
                            [post_content] => 
                            [post_title] => Ferring - MPP, Post-Partum Hemorrhage Prevention & Treatment (Heat Stable Carbetocin) MOU
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => ferring-mpp-post-partum-hemorrhage-prevention-treatment-heat-stable-carbetocin-mou
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-10-23 11:42:12
                            [post_modified_gmt] => 2025-10-23 11:42:12
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=13124
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [14] => WP_Post Object
                        (
                            [ID] => 11464
                            [post_author] => 5
                            [post_date] => 2023-11-15 09:55:17
                            [post_date_gmt] => 2023-11-15 09:55:17
                            [post_content] => 
                            [post_title] => GARDP – Orchid Pharma Ltd., Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => gardp-orchid-pharma-ltd-cefiderocol-manufacturing-sublicense-and-technology-transfer-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-08-20 11:47:20
                            [post_modified_gmt] => 2025-08-20 11:47:20
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11464
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [15] => WP_Post Object
                        (
                            [ID] => 3373
                            [post_author] => 5
                            [post_date] => 2021-06-30 16:31:33
                            [post_date_gmt] => 2021-06-30 16:31:33
                            [post_content] => 
                            [post_title] => Gates Foundation - CureVac - GSK, Letter Agreement for Alignment on Global Access Commitments
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => bmgf-curevac-gsk-letter-agreement-for-alignment-on-global-access-commitments
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:17:38
                            [post_modified_gmt] => 2022-10-11 12:17:38
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=3373
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [16] => WP_Post Object
                        (
                            [ID] => 1083
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:22:27
                            [post_date_gmt] => 2020-05-21 20:22:27
                            [post_content] => 
                            [post_title] => Gilead - MPP - Arene Lifesciences, HIV Therapeutic License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-gilead-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-09-27 10:45:18
                            [post_modified_gmt] => 2022-09-27 10:45:18
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1083
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [17] => WP_Post Object
                        (
                            [ID] => 1099
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:39:09
                            [post_date_gmt] => 2020-05-21 20:39:09
                            [post_content] => 
                            [post_title] => Gilead Hepatitis C (HCV) Therapeutics License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => gilead-indian-manufacturers-hcv-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-10-23 13:41:58
                            [post_modified_gmt] => 2024-10-23 13:41:58
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1099
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [18] => WP_Post Object
                        (
                            [ID] => 12137
                            [post_author] => 5
                            [post_date] => 2024-10-23 12:20:41
                            [post_date_gmt] => 2024-10-23 12:20:41
                            [post_content] => 
                            [post_title] => Gilead, HIV Therapeutic (Lenacapavir) Template License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => gilead-hiv-therapeutic-lenacapavir-template-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-10-23 12:20:41
                            [post_modified_gmt] => 2024-10-23 12:20:41
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12137
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [19] => WP_Post Object
                        (
                            [ID] => 12820
                            [post_author] => 5
                            [post_date] => 2025-06-30 13:59:06
                            [post_date_gmt] => 2025-06-30 13:59:06
                            [post_content] => 
                            [post_title] => Harvard - Tectonic Therapeutic, License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => harvard-tectonic-therapeutic-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-06-30 13:59:06
                            [post_modified_gmt] => 2025-06-30 13:59:06
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12820
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [20] => WP_Post Object
                        (
                            [ID] => 12903
                            [post_author] => 5
                            [post_date] => 2025-08-05 10:48:22
                            [post_date_gmt] => 2025-08-05 10:48:22
                            [post_content] => 
                            [post_title] => Johns Hopkins University - Aduro Biotech, Cancer Immunotherapy License and Materials Transfer Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => johns-hopkins-university-aduro-biotech-cancer-immunotherapy-license-and-materials-transfer-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-08-05 10:48:22
                            [post_modified_gmt] => 2025-08-05 10:48:22
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12903
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [21] => WP_Post Object
                        (
                            [ID] => 11343
                            [post_author] => 5
                            [post_date] => 2023-10-10 08:51:06
                            [post_date_gmt] => 2023-10-10 08:51:06
                            [post_content] => 
                            [post_title] => Medigen - MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-c-tap-medigen-covid-19-vaccine-patent-and-know-how-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-11 15:25:05
                            [post_modified_gmt] => 2023-10-11 15:25:05
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11343
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [22] => WP_Post Object
                        (
                            [ID] => 12775
                            [post_author] => 5
                            [post_date] => 2025-06-18 11:15:59
                            [post_date_gmt] => 2025-06-18 11:15:59
                            [post_content] => 
                            [post_title] => MedinCell - MPP, Malaria Vector Control (mdc-STM/ivermectin formulation) License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => medincell-mpp-malaria-vector-control-mdc-stm-ivermectin-formulation-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-06-18 11:15:59
                            [post_modified_gmt] => 2025-06-18 11:15:59
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12775
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [23] => WP_Post Object
                        (
                            [ID] => 1103
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:41:55
                            [post_date_gmt] => 2020-05-21 20:41:55
                            [post_content] => 
                            [post_title] => Merck - Bioprotection Systems Corp., Ebola Vaccine License & Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => merck-bsc-license-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:18:56
                            [post_modified_gmt] => 2022-10-11 12:18:56
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1103
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [24] => WP_Post Object
                        (
                            [ID] => 3888
                            [post_author] => 5
                            [post_date] => 2021-11-19 12:49:16
                            [post_date_gmt] => 2021-11-19 12:49:16
                            [post_content] => 
                            [post_title] => Merck - MPP, Molnupiravir License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => msd-mpp-molnupiravir-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-01-27 14:54:27
                            [post_modified_gmt] => 2023-01-27 14:54:27
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=3888
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [25] => WP_Post Object
                        (
                            [ID] => 12922
                            [post_author] => 5
                            [post_date] => 2025-09-01 08:01:35
                            [post_date_gmt] => 2025-09-01 08:01:35
                            [post_content] => 
                            [post_title] => MIT - Visterra, Dengue Monoclonal Antibody Patent License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mit-visterra-dengue-monoclonal-antibody-patent-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-09-01 08:01:36
                            [post_modified_gmt] => 2025-09-01 08:01:36
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12922
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [26] => WP_Post Object
                        (
                            [ID] => 12092
                            [post_author] => 5
                            [post_date] => 2024-10-08 10:45:15
                            [post_date_gmt] => 2024-10-08 10:45:15
                            [post_content] => 
                            [post_title] => MPP - Biovac, mRNA Vaccine Technology Transfer Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-biovac-mrna-vaccine-technology-transfer-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-10-09 14:56:39
                            [post_modified_gmt] => 2024-10-09 14:56:39
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12092
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [27] => WP_Post Object
                        (
                            [ID] => 11785
                            [post_author] => 5
                            [post_date] => 2024-05-30 15:07:27
                            [post_date_gmt] => 2024-05-30 15:07:27
                            [post_content] => 
                            [post_title] => MPP - Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-gates-medical-research-institute-tb-therapeutic-sutezolid-sublicense-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-05-30 15:07:27
                            [post_modified_gmt] => 2024-05-30 15:07:27
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11785
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [28] => WP_Post Object
                        (
                            [ID] => 11600
                            [post_author] => 5
                            [post_date] => 2024-01-25 08:39:06
                            [post_date_gmt] => 2024-01-25 08:39:06
                            [post_content] => 
                            [post_title] => MPP (C-TAP) - Biotech Africa, COVID-19 Diagnostic, Patent & Material Sublicense Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-c-tap-biotech-africa-covid-19-diagnostic-patent-material-sublicense-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-25 08:39:06
                            [post_modified_gmt] => 2024-01-25 08:39:06
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11600
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [29] => WP_Post Object
                        (
                            [ID] => 11722
                            [post_author] => 5
                            [post_date] => 2024-04-11 07:44:47
                            [post_date_gmt] => 2024-04-11 07:44:47
                            [post_content] => 
                            [post_title] => NIAID - AbCellera, COVID-19 Exclusive Patent License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => niaid-abcellera-covid-19-exclusive-patent-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-11 07:44:47
                            [post_modified_gmt] => 2024-04-11 07:44:47
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11722
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [30] => WP_Post Object
                        (
                            [ID] => 3404
                            [post_author] => 5
                            [post_date] => 2021-06-30 18:18:57
                            [post_date_gmt] => 2021-06-30 18:18:57
                            [post_content] => 
                            [post_title] => NIH - GeoVax, Non-Exclusive Patent and Biological Materials License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => nih-geovax-non-exclusive-patent-and-biological-materials-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2021-09-15 12:02:05
                            [post_modified_gmt] => 2021-09-15 12:02:05
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=3404
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [31] => WP_Post Object
                        (
                            [ID] => 1092
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:32:35
                            [post_date_gmt] => 2020-05-21 20:32:35
                            [post_content] => 
                            [post_title] => NIH - Non-Profit, Model License Agreement Terms
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => nih-model-license-agreement-for-use-by-non-profit
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2021-09-15 12:16:48
                            [post_modified_gmt] => 2021-09-15 12:16:48
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1092
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [32] => WP_Post Object
                        (
                            [ID] => 11094
                            [post_author] => 5
                            [post_date] => 2023-08-31 08:20:34
                            [post_date_gmt] => 2023-08-31 08:20:34
                            [post_content] => 
                            [post_title] => NIH - UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => nih-uniqure-aav5-gene-therapies-exclusive-and-non-exclusive-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-08-31 08:20:34
                            [post_modified_gmt] => 2023-08-31 08:20:34
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11094
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [33] => WP_Post Object
                        (
                            [ID] => 5110
                            [post_author] => 5
                            [post_date] => 2022-06-29 11:57:22
                            [post_date_gmt] => 2022-06-29 11:57:22
                            [post_content] => 
                            [post_title] => NIH – MPP (C-TAP), COVID-19 Technologies, Patent and Biological Material License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => nih-mpp-covid-19-patent-and-biological-material-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-18 11:58:40
                            [post_modified_gmt] => 2023-09-18 11:58:40
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=5110
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [34] => WP_Post Object
                        (
                            [ID] => 12012
                            [post_author] => 5
                            [post_date] => 2024-10-17 09:03:29
                            [post_date_gmt] => 2024-10-17 09:03:29
                            [post_content] => 
                            [post_title] => Novartis – MPP, Nilotinib, Non-Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => novartis-mpp-nilotinib-non-exclusive-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-10-17 09:03:29
                            [post_modified_gmt] => 2024-10-17 09:03:29
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12012
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [35] => WP_Post Object
                        (
                            [ID] => 3794
                            [post_author] => 5
                            [post_date] => 2021-09-10 08:02:49
                            [post_date_gmt] => 2021-09-10 08:02:49
                            [post_content] => 
                            [post_title] => Novavax - Serum Institute of India, COVID-19 Vaccine Supply and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => novavax-serum-institute-of-india-covid-19-vaccine-supply-and-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-02-20 13:22:55
                            [post_modified_gmt] => 2023-02-20 13:22:55
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=3794
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [36] => WP_Post Object
                        (
                            [ID] => 4026
                            [post_author] => 5
                            [post_date] => 2021-12-21 11:36:17
                            [post_date_gmt] => 2021-12-21 11:36:17
                            [post_content] => 
                            [post_title] => Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => ocugen-bbil-covid-19-vaccine-covaxin-co-development-supply-commercialization-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:21:01
                            [post_modified_gmt] => 2022-10-11 12:21:01
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=4026
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [37] => WP_Post Object
                        (
                            [ID] => 1091
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:31:42
                            [post_date_gmt] => 2020-05-21 20:31:42
                            [post_content] => 
                            [post_title] => Pfizer - MPP, TB Therapeutic (Sutezolid) Non-Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-pfizer-license-agreement-sutezolid
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-05-30 11:39:04
                            [post_modified_gmt] => 2024-05-30 11:39:04
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1091
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [38] => WP_Post Object
                        (
                            [ID] => 11063
                            [post_author] => 5
                            [post_date] => 2023-08-28 09:01:25
                            [post_date_gmt] => 2023-08-28 09:01:25
                            [post_content] => 
                            [post_title] => PHS - Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => phs-aridis-rotavirus-vaccine-exclusive-and-non-exclusive-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-08-28 09:01:25
                            [post_modified_gmt] => 2023-08-28 09:01:25
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11063
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [39] => WP_Post Object
                        (
                            [ID] => 11038
                            [post_author] => 5
                            [post_date] => 2023-08-24 10:34:46
                            [post_date_gmt] => 2023-08-24 10:34:46
                            [post_content] => 
                            [post_title] => PHS - Biosyn, HIV Prophylactic Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => nih-biosyn-hiv-prophylactic-exclusive-licence-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-08-28 08:17:11
                            [post_modified_gmt] => 2023-08-28 08:17:11
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11038
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [40] => WP_Post Object
                        (
                            [ID] => 11099
                            [post_author] => 5
                            [post_date] => 2023-08-31 10:33:35
                            [post_date_gmt] => 2023-08-31 10:33:35
                            [post_content] => 
                            [post_title] => PHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => phs-nih-cdc-fda-model-exclusive-patent-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-08-31 10:33:35
                            [post_modified_gmt] => 2023-08-31 10:33:35
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11099
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [41] => WP_Post Object
                        (
                            [ID] => 11079
                            [post_author] => 5
                            [post_date] => 2023-08-29 12:08:06
                            [post_date_gmt] => 2023-08-29 12:08:06
                            [post_content] => 
                            [post_title] => PHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => phs-nih-cdc-fda-model-non-exclusive-patent-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-08-29 12:08:06
                            [post_modified_gmt] => 2023-08-29 12:08:06
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11079
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [42] => WP_Post Object
                        (
                            [ID] => 11672
                            [post_author] => 5
                            [post_date] => 2024-03-27 06:43:58
                            [post_date_gmt] => 2024-03-27 06:43:58
                            [post_content] => 
                            [post_title] => Population Council - TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => population-council-therapeuticsmd-nestorone-contraceptive-ring-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-07-16 14:20:23
                            [post_modified_gmt] => 2024-07-16 14:20:23
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11672
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [43] => WP_Post Object
                        (
                            [ID] => 12846
                            [post_author] => 5
                            [post_date] => 2025-07-23 10:18:37
                            [post_date_gmt] => 2025-07-23 10:18:37
                            [post_content] => 
                            [post_title] => Protalix - Fiocruz, Gaucher Disease Therapy Technology Transfer and Supply Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => protalix-fiocruz-gaucher-disease-therapy-technology-transfer-and-supply-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-07-23 10:18:37
                            [post_modified_gmt] => 2025-07-23 10:18:37
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12846
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [44] => WP_Post Object
                        (
                            [ID] => 12992
                            [post_author] => 5
                            [post_date] => 2025-08-26 09:58:31
                            [post_date_gmt] => 2025-08-26 09:58:31
                            [post_content] => 
                            [post_title] => Public Health Agency of Canada (PHAC) - Bioprotection Systems Corp., Ebola Vaccine License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-agency-of-canada-phac-bioprotection-systems-corp-ebola-vaccine-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-08-26 09:58:31
                            [post_modified_gmt] => 2025-08-26 09:58:31
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12992
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [45] => WP_Post Object
                        (
                            [ID] => 2420
                            [post_author] => 5
                            [post_date] => 2020-12-14 14:59:07
                            [post_date_gmt] => 2020-12-14 14:59:07
                            [post_content] => 
                            [post_title] => Sanofi - Translate Bio, Influenza and COVID-19 Vaccine Collaboration & License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => collaboration-and-license-agreement-between-sanofi-pasteur-inc-sanofi-and-translate-bio-ma-inc-translate-bio-or-tb-and-first-amendment-co
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:21:49
                            [post_modified_gmt] => 2022-10-11 12:21:49
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=2420
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [46] => WP_Post Object
                        (
                            [ID] => 5267
                            [post_author] => 5
                            [post_date] => 2022-07-07 13:47:03
                            [post_date_gmt] => 2022-07-07 13:47:03
                            [post_content] => 
                            [post_title] => Shionogi - GARDP, Cefiderocol License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => shionogi-gardp-cefiderocol-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2022-10-11 12:22:05
                            [post_modified_gmt] => 2022-10-11 12:22:05
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=5267
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [47] => WP_Post Object
                        (
                            [ID] => 12108
                            [post_author] => 5
                            [post_date] => 2024-11-22 12:46:28
                            [post_date_gmt] => 2024-11-22 12:46:28
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-02 15:59:57
                            [post_modified_gmt] => 2024-12-02 15:59:57
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12108
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [48] => WP_Post Object
                        (
                            [ID] => 11543
                            [post_author] => 5
                            [post_date] => 2023-11-30 12:38:56
                            [post_date_gmt] => 2023-11-30 12:38:56
                            [post_content] => 
                            [post_title] => UC Berkeley, Therapeutics & Diagnostics, Exclusive License Agreement Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uc-berkeley-therapeutics-diagnostics-exclusive-license-agreement-template
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-11-30 12:38:56
                            [post_modified_gmt] => 2023-11-30 12:38:56
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11543
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [49] => WP_Post Object
                        (
                            [ID] => 12678
                            [post_author] => 5
                            [post_date] => 2025-04-28 08:54:33
                            [post_date_gmt] => 2025-04-28 08:54:33
                            [post_content] => 
                            [post_title] => UCLA - Radiopharm Theranostics, Cancer Therapeutic & Diagnostic (DUNP19 antibody) License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => ucla-radiopharm-theranostics-cancer-therapeutic-diagnostic-dunp19-antibody-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-04-28 08:54:33
                            [post_modified_gmt] => 2025-04-28 08:54:33
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12678
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [50] => WP_Post Object
                        (
                            [ID] => 11568
                            [post_author] => 5
                            [post_date] => 2023-12-20 08:15:11
                            [post_date_gmt] => 2023-12-20 08:15:11
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-20 08:15:11
                            [post_modified_gmt] => 2023-12-20 08:15:11
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11568
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [51] => WP_Post Object
                        (
                            [ID] => 11325
                            [post_author] => 5
                            [post_date] => 2023-09-25 16:05:58
                            [post_date_gmt] => 2023-09-25 16:05:58
                            [post_content] => 
                            [post_title] => University of Chile - MPP (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => university-of-chile-mpp-c-tap-covid-19-diagnostic-material-know-how-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-26 10:26:26
                            [post_modified_gmt] => 2023-09-26 10:26:26
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=11325
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [52] => WP_Post Object
                        (
                            [ID] => 1086
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:26:24
                            [post_date_gmt] => 2020-05-21 20:26:24
                            [post_content] => 
                            [post_title] => University of Liverpool – MPP, HIV Therapeutic Collaboration Agreement and Patent & Know-How License
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-univ-of-liverpool-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-07 10:44:07
                            [post_modified_gmt] => 2025-01-07 10:44:07
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1086
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [53] => WP_Post Object
                        (
                            [ID] => 13069
                            [post_author] => 5
                            [post_date] => 2025-09-09 07:57:07
                            [post_date_gmt] => 2025-09-09 07:57:07
                            [post_content] => 
                            [post_title] => University of Michigan Template Therapeutics License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => university-of-michigan-template-therapeutics-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-09-09 07:57:07
                            [post_modified_gmt] => 2025-09-09 07:57:07
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=13069
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [54] => WP_Post Object
                        (
                            [ID] => 4070
                            [post_author] => 5
                            [post_date] => 2022-01-08 12:53:25
                            [post_date_gmt] => 2022-01-08 12:53:25
                            [post_content] => 
                            [post_title] => University of Washington - MPP, Long-acting Injectable HIV Treatment License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => university-of-washington-medicines-patent-pool-long-acting-injectable-hiv-treatment-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-18 12:02:20
                            [post_modified_gmt] => 2023-09-18 12:02:20
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=4070
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [55] => WP_Post Object
                        (
                            [ID] => 12753
                            [post_author] => 5
                            [post_date] => 2025-06-13 14:21:59
                            [post_date_gmt] => 2025-06-13 14:21:59
                            [post_content] => 
                            [post_title] => Valneva - Serum Institute of India, Chikungunya Vaccine License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => valneva-serum-institute-of-india-chikungunya-vaccine-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-06-13 14:21:59
                            [post_modified_gmt] => 2025-06-13 14:21:59
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12753
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [56] => WP_Post Object
                        (
                            [ID] => 1089
                            [post_author] => 6
                            [post_date] => 2020-05-21 20:30:11
                            [post_date_gmt] => 2020-05-21 20:30:11
                            [post_content] => 
                            [post_title] => ViiV - MPP, Dolutegravir License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-viiv-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-18 12:02:03
                            [post_modified_gmt] => 2023-09-18 12:02:03
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1089
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [57] => WP_Post Object
                        (
                            [ID] => 12707
                            [post_author] => 5
                            [post_date] => 2025-05-22 08:54:31
                            [post_date_gmt] => 2025-05-22 08:54:31
                            [post_content] => 
                            [post_title] => ViiV - MPP, HIV Prevention Medicine (Cabotegravir LA for PrEP), License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => viiv-mpp-hiv-prevention-medicine-cabotegravir-la-for-prep-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-05-22 08:54:31
                            [post_modified_gmt] => 2025-05-22 08:54:31
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12707
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [58] => WP_Post Object
                        (
                            [ID] => 12731
                            [post_author] => 5
                            [post_date] => 2025-05-27 14:10:49
                            [post_date_gmt] => 2025-05-27 14:10:49
                            [post_content] => 
                            [post_title] => Visterra - Serum Institute of India, Dengue Fever Therapeutic, License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => visterra-serum-institute-of-india-dengue-fever-therapeutic-license-and-collaboration-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-05-27 14:10:49
                            [post_modified_gmt] => 2025-05-27 14:10:49
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=12731
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [59] => WP_Post Object
                        (
                            [ID] => 9033
                            [post_author] => 5
                            [post_date] => 2023-03-03 10:59:48
                            [post_date_gmt] => 2023-03-03 10:59:48
                            [post_content] => 
                            [post_title] => Yale University - BIND Biosciences, Cancer Therapeutic, Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => bind-biosciences-inc-yale-university-cancer-therapeutic-exclusive-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-11-30 12:33:02
                            [post_modified_gmt] => 2023-11-30 12:33:02
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=agreement&p=9033
                            [menu_order] => 0
                            [post_type] => agreement
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                )

            [post_count] => 60
            [current_post] => -1
            [before_loop] => 1
            [in_the_loop] => 
            [post] => WP_Post Object
                (
                    [ID] => 1084
                    [post_author] => 6
                    [post_date] => 2020-05-21 20:23:34
                    [post_date_gmt] => 2020-05-21 20:23:34
                    [post_content] => 
                    [post_title] => AbbVie - MPP, HIV Antiretroviral (lopinavir, ritonavir - LPV/r) Pediatric License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => mpp-abbvie-sublicense-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-06 13:36:22
                    [post_modified_gmt] => 2024-09-06 13:36:22
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.swantondevelopment.ca/?post_type=agreement&p=1084
                    [menu_order] => 0
                    [post_type] => agreement
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [comment_count] => 0
            [current_comment] => -1
            [found_posts] => 60
            [max_num_pages] => 0
            [max_num_comment_pages] => 0
            [is_single] => 
            [is_preview] => 
            [is_page] => 
            [is_archive] => 1
            [is_date] => 
            [is_year] => 
            [is_month] => 
            [is_day] => 
            [is_time] => 
            [is_author] => 
            [is_category] => 
            [is_tag] => 
            [is_tax] => 1
            [is_search] => 
            [is_feed] => 
            [is_comment_feed] => 
            [is_trackback] => 
            [is_home] => 
            [is_privacy_policy] => 
            [is_404] => 
            [is_embed] => 
            [is_paged] => 
            [is_admin] => 
            [is_attachment] => 
            [is_singular] => 
            [is_robots] => 
            [is_favicon] => 
            [is_posts_page] => 
            [is_post_type_archive] => 1
            [query_vars_hash:WP_Query:private] => e64640c006c6ed735b67198eb04aaaca
            [query_vars_changed:WP_Query:private] => 1
            [thumbnails_cached] => 
            [allow_query_attachment_by_filename:protected] => 
            [stopwords:WP_Query:private] => 
            [compat_fields:WP_Query:private] => Array
                (
                    [0] => query_vars_hash
                    [1] => query_vars_changed
                )

            [compat_methods:WP_Query:private] => Array
                (
                    [0] => init_query_flags
                    [1] => parse_tax_query
                )

            [query_cache_key:WP_Query:private] => wp_query:290723f226c68cac14f3937433d72176
        )

    [provision_q_rslts] => WP_Query Object
        (
            [query] => Array
                (
                    [post_type] => provision_document
                    [posts_per_page] => -1
                    [tax_query] => Array
                        (
                            [0] => Array
                                (
                                    [taxonomy] => issue
                                    [field] => slug
                                    [terms] => Array
                                        (
                                            [0] => roles-responsibilities
                                        )

                                )

                        )

                    [meta_query] => Array
                        (
                            [relation] => OR
                            [0] => Array
                                (
                                    [key] => agreement
                                    [value] => "1084"
                                    [compare] => LIKE
                                )

                            [1] => Array
                                (
                                    [key] => agreement
                                    [value] => "1087"
                                    [compare] => LIKE
                                )

                            [2] => Array
                                (
                                    [key] => agreement
                                    [value] => "12797"
                                    [compare] => LIKE
                                )

                            [3] => Array
                                (
                                    [key] => agreement
                                    [value] => "1088"
                                    [compare] => LIKE
                                )

                            [4] => Array
                                (
                                    [key] => agreement
                                    [value] => "1090"
                                    [compare] => LIKE
                                )

                            [5] => Array
                                (
                                    [key] => agreement
                                    [value] => "1039"
                                    [compare] => LIKE
                                )

                            [6] => Array
                                (
                                    [key] => agreement
                                    [value] => "4467"
                                    [compare] => LIKE
                                )

                            [7] => Array
                                (
                                    [key] => agreement
                                    [value] => "4794"
                                    [compare] => LIKE
                                )

                            [8] => Array
                                (
                                    [key] => agreement
                                    [value] => "11245"
                                    [compare] => LIKE
                                )

                            [9] => Array
                                (
                                    [key] => agreement
                                    [value] => "3817"
                                    [compare] => LIKE
                                )

                            [10] => Array
                                (
                                    [key] => agreement
                                    [value] => "9858"
                                    [compare] => LIKE
                                )

                            [11] => Array
                                (
                                    [key] => agreement
                                    [value] => "9849"
                                    [compare] => LIKE
                                )

                            [12] => Array
                                (
                                    [key] => agreement
                                    [value] => "4832"
                                    [compare] => LIKE
                                )

                            [13] => Array
                                (
                                    [key] => agreement
                                    [value] => "13124"
                                    [compare] => LIKE
                                )

                            [14] => Array
                                (
                                    [key] => agreement
                                    [value] => "11464"
                                    [compare] => LIKE
                                )

                            [15] => Array
                                (
                                    [key] => agreement
                                    [value] => "3373"
                                    [compare] => LIKE
                                )

                            [16] => Array
                                (
                                    [key] => agreement
                                    [value] => "1083"
                                    [compare] => LIKE
                                )

                            [17] => Array
                                (
                                    [key] => agreement
                                    [value] => "1099"
                                    [compare] => LIKE
                                )

                            [18] => Array
                                (
                                    [key] => agreement
                                    [value] => "12137"
                                    [compare] => LIKE
                                )

                            [19] => Array
                                (
                                    [key] => agreement
                                    [value] => "12820"
                                    [compare] => LIKE
                                )

                            [20] => Array
                                (
                                    [key] => agreement
                                    [value] => "12903"
                                    [compare] => LIKE
                                )

                            [21] => Array
                                (
                                    [key] => agreement
                                    [value] => "11343"
                                    [compare] => LIKE
                                )

                            [22] => Array
                                (
                                    [key] => agreement
                                    [value] => "12775"
                                    [compare] => LIKE
                                )

                            [23] => Array
                                (
                                    [key] => agreement
                                    [value] => "1103"
                                    [compare] => LIKE
                                )

                            [24] => Array
                                (
                                    [key] => agreement
                                    [value] => "3888"
                                    [compare] => LIKE
                                )

                            [25] => Array
                                (
                                    [key] => agreement
                                    [value] => "12922"
                                    [compare] => LIKE
                                )

                            [26] => Array
                                (
                                    [key] => agreement
                                    [value] => "12092"
                                    [compare] => LIKE
                                )

                            [27] => Array
                                (
                                    [key] => agreement
                                    [value] => "11785"
                                    [compare] => LIKE
                                )

                            [28] => Array
                                (
                                    [key] => agreement
                                    [value] => "11600"
                                    [compare] => LIKE
                                )

                            [29] => Array
                                (
                                    [key] => agreement
                                    [value] => "11722"
                                    [compare] => LIKE
                                )

                            [30] => Array
                                (
                                    [key] => agreement
                                    [value] => "3404"
                                    [compare] => LIKE
                                )

                            [31] => Array
                                (
                                    [key] => agreement
                                    [value] => "1092"
                                    [compare] => LIKE
                                )

                            [32] => Array
                                (
                                    [key] => agreement
                                    [value] => "11094"
                                    [compare] => LIKE
                                )

                            [33] => Array
                                (
                                    [key] => agreement
                                    [value] => "5110"
                                    [compare] => LIKE
                                )

                            [34] => Array
                                (
                                    [key] => agreement
                                    [value] => "12012"
                                    [compare] => LIKE
                                )

                            [35] => Array
                                (
                                    [key] => agreement
                                    [value] => "3794"
                                    [compare] => LIKE
                                )

                            [36] => Array
                                (
                                    [key] => agreement
                                    [value] => "4026"
                                    [compare] => LIKE
                                )

                            [37] => Array
                                (
                                    [key] => agreement
                                    [value] => "1091"
                                    [compare] => LIKE
                                )

                            [38] => Array
                                (
                                    [key] => agreement
                                    [value] => "11063"
                                    [compare] => LIKE
                                )

                            [39] => Array
                                (
                                    [key] => agreement
                                    [value] => "11038"
                                    [compare] => LIKE
                                )

                            [40] => Array
                                (
                                    [key] => agreement
                                    [value] => "11099"
                                    [compare] => LIKE
                                )

                            [41] => Array
                                (
                                    [key] => agreement
                                    [value] => "11079"
                                    [compare] => LIKE
                                )

                            [42] => Array
                                (
                                    [key] => agreement
                                    [value] => "11672"
                                    [compare] => LIKE
                                )

                            [43] => Array
                                (
                                    [key] => agreement
                                    [value] => "12846"
                                    [compare] => LIKE
                                )

                            [44] => Array
                                (
                                    [key] => agreement
                                    [value] => "12992"
                                    [compare] => LIKE
                                )

                            [45] => Array
                                (
                                    [key] => agreement
                                    [value] => "2420"
                                    [compare] => LIKE
                                )

                            [46] => Array
                                (
                                    [key] => agreement
                                    [value] => "5267"
                                    [compare] => LIKE
                                )

                            [47] => Array
                                (
                                    [key] => agreement
                                    [value] => "12108"
                                    [compare] => LIKE
                                )

                            [48] => Array
                                (
                                    [key] => agreement
                                    [value] => "11543"
                                    [compare] => LIKE
                                )

                            [49] => Array
                                (
                                    [key] => agreement
                                    [value] => "12678"
                                    [compare] => LIKE
                                )

                            [50] => Array
                                (
                                    [key] => agreement
                                    [value] => "11568"
                                    [compare] => LIKE
                                )

                            [51] => Array
                                (
                                    [key] => agreement
                                    [value] => "11325"
                                    [compare] => LIKE
                                )

                            [52] => Array
                                (
                                    [key] => agreement
                                    [value] => "1086"
                                    [compare] => LIKE
                                )

                            [53] => Array
                                (
                                    [key] => agreement
                                    [value] => "13069"
                                    [compare] => LIKE
                                )

                            [54] => Array
                                (
                                    [key] => agreement
                                    [value] => "4070"
                                    [compare] => LIKE
                                )

                            [55] => Array
                                (
                                    [key] => agreement
                                    [value] => "12753"
                                    [compare] => LIKE
                                )

                            [56] => Array
                                (
                                    [key] => agreement
                                    [value] => "1089"
                                    [compare] => LIKE
                                )

                            [57] => Array
                                (
                                    [key] => agreement
                                    [value] => "12707"
                                    [compare] => LIKE
                                )

                            [58] => Array
                                (
                                    [key] => agreement
                                    [value] => "12731"
                                    [compare] => LIKE
                                )

                            [59] => Array
                                (
                                    [key] => agreement
                                    [value] => "9033"
                                    [compare] => LIKE
                                )

                        )

                )

            [query_vars] => Array
                (
                    [post_type] => provision_document
                    [posts_per_page] => -1
                    [tax_query] => Array
                        (
                            [0] => Array
                                (
                                    [taxonomy] => issue
                                    [field] => slug
                                    [terms] => Array
                                        (
                                            [0] => roles-responsibilities
                                        )

                                )

                        )

                    [meta_query] => Array
                        (
                            [relation] => OR
                            [0] => Array
                                (
                                    [key] => agreement
                                    [value] => "1084"
                                    [compare] => LIKE
                                )

                            [1] => Array
                                (
                                    [key] => agreement
                                    [value] => "1087"
                                    [compare] => LIKE
                                )

                            [2] => Array
                                (
                                    [key] => agreement
                                    [value] => "12797"
                                    [compare] => LIKE
                                )

                            [3] => Array
                                (
                                    [key] => agreement
                                    [value] => "1088"
                                    [compare] => LIKE
                                )

                            [4] => Array
                                (
                                    [key] => agreement
                                    [value] => "1090"
                                    [compare] => LIKE
                                )

                            [5] => Array
                                (
                                    [key] => agreement
                                    [value] => "1039"
                                    [compare] => LIKE
                                )

                            [6] => Array
                                (
                                    [key] => agreement
                                    [value] => "4467"
                                    [compare] => LIKE
                                )

                            [7] => Array
                                (
                                    [key] => agreement
                                    [value] => "4794"
                                    [compare] => LIKE
                                )

                            [8] => Array
                                (
                                    [key] => agreement
                                    [value] => "11245"
                                    [compare] => LIKE
                                )

                            [9] => Array
                                (
                                    [key] => agreement
                                    [value] => "3817"
                                    [compare] => LIKE
                                )

                            [10] => Array
                                (
                                    [key] => agreement
                                    [value] => "9858"
                                    [compare] => LIKE
                                )

                            [11] => Array
                                (
                                    [key] => agreement
                                    [value] => "9849"
                                    [compare] => LIKE
                                )

                            [12] => Array
                                (
                                    [key] => agreement
                                    [value] => "4832"
                                    [compare] => LIKE
                                )

                            [13] => Array
                                (
                                    [key] => agreement
                                    [value] => "13124"
                                    [compare] => LIKE
                                )

                            [14] => Array
                                (
                                    [key] => agreement
                                    [value] => "11464"
                                    [compare] => LIKE
                                )

                            [15] => Array
                                (
                                    [key] => agreement
                                    [value] => "3373"
                                    [compare] => LIKE
                                )

                            [16] => Array
                                (
                                    [key] => agreement
                                    [value] => "1083"
                                    [compare] => LIKE
                                )

                            [17] => Array
                                (
                                    [key] => agreement
                                    [value] => "1099"
                                    [compare] => LIKE
                                )

                            [18] => Array
                                (
                                    [key] => agreement
                                    [value] => "12137"
                                    [compare] => LIKE
                                )

                            [19] => Array
                                (
                                    [key] => agreement
                                    [value] => "12820"
                                    [compare] => LIKE
                                )

                            [20] => Array
                                (
                                    [key] => agreement
                                    [value] => "12903"
                                    [compare] => LIKE
                                )

                            [21] => Array
                                (
                                    [key] => agreement
                                    [value] => "11343"
                                    [compare] => LIKE
                                )

                            [22] => Array
                                (
                                    [key] => agreement
                                    [value] => "12775"
                                    [compare] => LIKE
                                )

                            [23] => Array
                                (
                                    [key] => agreement
                                    [value] => "1103"
                                    [compare] => LIKE
                                )

                            [24] => Array
                                (
                                    [key] => agreement
                                    [value] => "3888"
                                    [compare] => LIKE
                                )

                            [25] => Array
                                (
                                    [key] => agreement
                                    [value] => "12922"
                                    [compare] => LIKE
                                )

                            [26] => Array
                                (
                                    [key] => agreement
                                    [value] => "12092"
                                    [compare] => LIKE
                                )

                            [27] => Array
                                (
                                    [key] => agreement
                                    [value] => "11785"
                                    [compare] => LIKE
                                )

                            [28] => Array
                                (
                                    [key] => agreement
                                    [value] => "11600"
                                    [compare] => LIKE
                                )

                            [29] => Array
                                (
                                    [key] => agreement
                                    [value] => "11722"
                                    [compare] => LIKE
                                )

                            [30] => Array
                                (
                                    [key] => agreement
                                    [value] => "3404"
                                    [compare] => LIKE
                                )

                            [31] => Array
                                (
                                    [key] => agreement
                                    [value] => "1092"
                                    [compare] => LIKE
                                )

                            [32] => Array
                                (
                                    [key] => agreement
                                    [value] => "11094"
                                    [compare] => LIKE
                                )

                            [33] => Array
                                (
                                    [key] => agreement
                                    [value] => "5110"
                                    [compare] => LIKE
                                )

                            [34] => Array
                                (
                                    [key] => agreement
                                    [value] => "12012"
                                    [compare] => LIKE
                                )

                            [35] => Array
                                (
                                    [key] => agreement
                                    [value] => "3794"
                                    [compare] => LIKE
                                )

                            [36] => Array
                                (
                                    [key] => agreement
                                    [value] => "4026"
                                    [compare] => LIKE
                                )

                            [37] => Array
                                (
                                    [key] => agreement
                                    [value] => "1091"
                                    [compare] => LIKE
                                )

                            [38] => Array
                                (
                                    [key] => agreement
                                    [value] => "11063"
                                    [compare] => LIKE
                                )

                            [39] => Array
                                (
                                    [key] => agreement
                                    [value] => "11038"
                                    [compare] => LIKE
                                )

                            [40] => Array
                                (
                                    [key] => agreement
                                    [value] => "11099"
                                    [compare] => LIKE
                                )

                            [41] => Array
                                (
                                    [key] => agreement
                                    [value] => "11079"
                                    [compare] => LIKE
                                )

                            [42] => Array
                                (
                                    [key] => agreement
                                    [value] => "11672"
                                    [compare] => LIKE
                                )

                            [43] => Array
                                (
                                    [key] => agreement
                                    [value] => "12846"
                                    [compare] => LIKE
                                )

                            [44] => Array
                                (
                                    [key] => agreement
                                    [value] => "12992"
                                    [compare] => LIKE
                                )

                            [45] => Array
                                (
                                    [key] => agreement
                                    [value] => "2420"
                                    [compare] => LIKE
                                )

                            [46] => Array
                                (
                                    [key] => agreement
                                    [value] => "5267"
                                    [compare] => LIKE
                                )

                            [47] => Array
                                (
                                    [key] => agreement
                                    [value] => "12108"
                                    [compare] => LIKE
                                )

                            [48] => Array
                                (
                                    [key] => agreement
                                    [value] => "11543"
                                    [compare] => LIKE
                                )

                            [49] => Array
                                (
                                    [key] => agreement
                                    [value] => "12678"
                                    [compare] => LIKE
                                )

                            [50] => Array
                                (
                                    [key] => agreement
                                    [value] => "11568"
                                    [compare] => LIKE
                                )

                            [51] => Array
                                (
                                    [key] => agreement
                                    [value] => "11325"
                                    [compare] => LIKE
                                )

                            [52] => Array
                                (
                                    [key] => agreement
                                    [value] => "1086"
                                    [compare] => LIKE
                                )

                            [53] => Array
                                (
                                    [key] => agreement
                                    [value] => "13069"
                                    [compare] => LIKE
                                )

                            [54] => Array
                                (
                                    [key] => agreement
                                    [value] => "4070"
                                    [compare] => LIKE
                                )

                            [55] => Array
                                (
                                    [key] => agreement
                                    [value] => "12753"
                                    [compare] => LIKE
                                )

                            [56] => Array
                                (
                                    [key] => agreement
                                    [value] => "1089"
                                    [compare] => LIKE
                                )

                            [57] => Array
                                (
                                    [key] => agreement
                                    [value] => "12707"
                                    [compare] => LIKE
                                )

                            [58] => Array
                                (
                                    [key] => agreement
                                    [value] => "12731"
                                    [compare] => LIKE
                                )

                            [59] => Array
                                (
                                    [key] => agreement
                                    [value] => "9033"
                                    [compare] => LIKE
                                )

                        )

                    [error] => 
                    [m] => 
                    [p] => 0
                    [post_parent] => 
                    [subpost] => 
                    [subpost_id] => 
                    [attachment] => 
                    [attachment_id] => 0
                    [name] => 
                    [pagename] => 
                    [page_id] => 0
                    [second] => 
                    [minute] => 
                    [hour] => 
                    [day] => 0
                    [monthnum] => 0
                    [year] => 0
                    [w] => 0
                    [category_name] => 
                    [tag] => 
                    [cat] => 
                    [tag_id] => 
                    [author] => 
                    [author_name] => 
                    [feed] => 
                    [tb] => 
                    [paged] => 0
                    [meta_key] => 
                    [meta_value] => 
                    [preview] => 
                    [s] => 
                    [sentence] => 
                    [title] => 
                    [fields] => all
                    [menu_order] => 
                    [embed] => 
                    [category__in] => Array
                        (
                        )

                    [category__not_in] => Array
                        (
                        )

                    [category__and] => Array
                        (
                        )

                    [post__in] => Array
                        (
                        )

                    [post__not_in] => Array
                        (
                        )

                    [post_name__in] => Array
                        (
                        )

                    [tag__in] => Array
                        (
                        )

                    [tag__not_in] => Array
                        (
                        )

                    [tag__and] => Array
                        (
                        )

                    [tag_slug__in] => Array
                        (
                        )

                    [tag_slug__and] => Array
                        (
                        )

                    [post_parent__in] => Array
                        (
                        )

                    [post_parent__not_in] => Array
                        (
                        )

                    [author__in] => Array
                        (
                        )

                    [author__not_in] => Array
                        (
                        )

                    [search_columns] => Array
                        (
                        )

                    [ignore_sticky_posts] => 
                    [suppress_filters] => 
                    [cache_results] => 1
                    [update_post_term_cache] => 1
                    [update_menu_item_cache] => 
                    [lazy_load_term_meta] => 1
                    [update_post_meta_cache] => 1
                    [nopaging] => 1
                    [comments_per_page] => 50
                    [no_found_rows] => 
                    [taxonomy] => issue
                    [term] => roles-responsibilities
                    [order] => DESC
                )

            [tax_query] => WP_Tax_Query Object
                (
                    [queries] => Array
                        (
                            [0] => Array
                                (
                                    [taxonomy] => issue
                                    [terms] => Array
                                        (
                                            [0] => roles-responsibilities
                                        )

                                    [field] => slug
                                    [operator] => IN
                                    [include_children] => 1
                                )

                        )

                    [relation] => AND
                    [table_aliases:protected] => Array
                        (
                            [0] => wpry_term_relationships
                        )

                    [queried_terms] => Array
                        (
                            [issue] => Array
                                (
                                    [terms] => Array
                                        (
                                            [0] => roles-responsibilities
                                        )

                                    [field] => slug
                                )

                        )

                    [primary_table] => wpry_posts
                    [primary_id_column] => ID
                )

            [meta_query] => WP_Meta_Query Object
                (
                    [queries] => Array
                        (
                            [0] => Array
                                (
                                    [key] => agreement
                                    [value] => "1084"
                                    [compare] => LIKE
                                )

                            [1] => Array
                                (
                                    [key] => agreement
                                    [value] => "1087"
                                    [compare] => LIKE
                                )

                            [2] => Array
                                (
                                    [key] => agreement
                                    [value] => "12797"
                                    [compare] => LIKE
                                )

                            [3] => Array
                                (
                                    [key] => agreement
                                    [value] => "1088"
                                    [compare] => LIKE
                                )

                            [4] => Array
                                (
                                    [key] => agreement
                                    [value] => "1090"
                                    [compare] => LIKE
                                )

                            [5] => Array
                                (
                                    [key] => agreement
                                    [value] => "1039"
                                    [compare] => LIKE
                                )

                            [6] => Array
                                (
                                    [key] => agreement
                                    [value] => "4467"
                                    [compare] => LIKE
                                )

                            [7] => Array
                                (
                                    [key] => agreement
                                    [value] => "4794"
                                    [compare] => LIKE
                                )

                            [8] => Array
                                (
                                    [key] => agreement
                                    [value] => "11245"
                                    [compare] => LIKE
                                )

                            [9] => Array
                                (
                                    [key] => agreement
                                    [value] => "3817"
                                    [compare] => LIKE
                                )

                            [10] => Array
                                (
                                    [key] => agreement
                                    [value] => "9858"
                                    [compare] => LIKE
                                )

                            [11] => Array
                                (
                                    [key] => agreement
                                    [value] => "9849"
                                    [compare] => LIKE
                                )

                            [12] => Array
                                (
                                    [key] => agreement
                                    [value] => "4832"
                                    [compare] => LIKE
                                )

                            [13] => Array
                                (
                                    [key] => agreement
                                    [value] => "13124"
                                    [compare] => LIKE
                                )

                            [14] => Array
                                (
                                    [key] => agreement
                                    [value] => "11464"
                                    [compare] => LIKE
                                )

                            [15] => Array
                                (
                                    [key] => agreement
                                    [value] => "3373"
                                    [compare] => LIKE
                                )

                            [16] => Array
                                (
                                    [key] => agreement
                                    [value] => "1083"
                                    [compare] => LIKE
                                )

                            [17] => Array
                                (
                                    [key] => agreement
                                    [value] => "1099"
                                    [compare] => LIKE
                                )

                            [18] => Array
                                (
                                    [key] => agreement
                                    [value] => "12137"
                                    [compare] => LIKE
                                )

                            [19] => Array
                                (
                                    [key] => agreement
                                    [value] => "12820"
                                    [compare] => LIKE
                                )

                            [20] => Array
                                (
                                    [key] => agreement
                                    [value] => "12903"
                                    [compare] => LIKE
                                )

                            [21] => Array
                                (
                                    [key] => agreement
                                    [value] => "11343"
                                    [compare] => LIKE
                                )

                            [22] => Array
                                (
                                    [key] => agreement
                                    [value] => "12775"
                                    [compare] => LIKE
                                )

                            [23] => Array
                                (
                                    [key] => agreement
                                    [value] => "1103"
                                    [compare] => LIKE
                                )

                            [24] => Array
                                (
                                    [key] => agreement
                                    [value] => "3888"
                                    [compare] => LIKE
                                )

                            [25] => Array
                                (
                                    [key] => agreement
                                    [value] => "12922"
                                    [compare] => LIKE
                                )

                            [26] => Array
                                (
                                    [key] => agreement
                                    [value] => "12092"
                                    [compare] => LIKE
                                )

                            [27] => Array
                                (
                                    [key] => agreement
                                    [value] => "11785"
                                    [compare] => LIKE
                                )

                            [28] => Array
                                (
                                    [key] => agreement
                                    [value] => "11600"
                                    [compare] => LIKE
                                )

                            [29] => Array
                                (
                                    [key] => agreement
                                    [value] => "11722"
                                    [compare] => LIKE
                                )

                            [30] => Array
                                (
                                    [key] => agreement
                                    [value] => "3404"
                                    [compare] => LIKE
                                )

                            [31] => Array
                                (
                                    [key] => agreement
                                    [value] => "1092"
                                    [compare] => LIKE
                                )

                            [32] => Array
                                (
                                    [key] => agreement
                                    [value] => "11094"
                                    [compare] => LIKE
                                )

                            [33] => Array
                                (
                                    [key] => agreement
                                    [value] => "5110"
                                    [compare] => LIKE
                                )

                            [34] => Array
                                (
                                    [key] => agreement
                                    [value] => "12012"
                                    [compare] => LIKE
                                )

                            [35] => Array
                                (
                                    [key] => agreement
                                    [value] => "3794"
                                    [compare] => LIKE
                                )

                            [36] => Array
                                (
                                    [key] => agreement
                                    [value] => "4026"
                                    [compare] => LIKE
                                )

                            [37] => Array
                                (
                                    [key] => agreement
                                    [value] => "1091"
                                    [compare] => LIKE
                                )

                            [38] => Array
                                (
                                    [key] => agreement
                                    [value] => "11063"
                                    [compare] => LIKE
                                )

                            [39] => Array
                                (
                                    [key] => agreement
                                    [value] => "11038"
                                    [compare] => LIKE
                                )

                            [40] => Array
                                (
                                    [key] => agreement
                                    [value] => "11099"
                                    [compare] => LIKE
                                )

                            [41] => Array
                                (
                                    [key] => agreement
                                    [value] => "11079"
                                    [compare] => LIKE
                                )

                            [42] => Array
                                (
                                    [key] => agreement
                                    [value] => "11672"
                                    [compare] => LIKE
                                )

                            [43] => Array
                                (
                                    [key] => agreement
                                    [value] => "12846"
                                    [compare] => LIKE
                                )

                            [44] => Array
                                (
                                    [key] => agreement
                                    [value] => "12992"
                                    [compare] => LIKE
                                )

                            [45] => Array
                                (
                                    [key] => agreement
                                    [value] => "2420"
                                    [compare] => LIKE
                                )

                            [46] => Array
                                (
                                    [key] => agreement
                                    [value] => "5267"
                                    [compare] => LIKE
                                )

                            [47] => Array
                                (
                                    [key] => agreement
                                    [value] => "12108"
                                    [compare] => LIKE
                                )

                            [48] => Array
                                (
                                    [key] => agreement
                                    [value] => "11543"
                                    [compare] => LIKE
                                )

                            [49] => Array
                                (
                                    [key] => agreement
                                    [value] => "12678"
                                    [compare] => LIKE
                                )

                            [50] => Array
                                (
                                    [key] => agreement
                                    [value] => "11568"
                                    [compare] => LIKE
                                )

                            [51] => Array
                                (
                                    [key] => agreement
                                    [value] => "11325"
                                    [compare] => LIKE
                                )

                            [52] => Array
                                (
                                    [key] => agreement
                                    [value] => "1086"
                                    [compare] => LIKE
                                )

                            [53] => Array
                                (
                                    [key] => agreement
                                    [value] => "13069"
                                    [compare] => LIKE
                                )

                            [54] => Array
                                (
                                    [key] => agreement
                                    [value] => "4070"
                                    [compare] => LIKE
                                )

                            [55] => Array
                                (
                                    [key] => agreement
                                    [value] => "12753"
                                    [compare] => LIKE
                                )

                            [56] => Array
                                (
                                    [key] => agreement
                                    [value] => "1089"
                                    [compare] => LIKE
                                )

                            [57] => Array
                                (
                                    [key] => agreement
                                    [value] => "12707"
                                    [compare] => LIKE
                                )

                            [58] => Array
                                (
                                    [key] => agreement
                                    [value] => "12731"
                                    [compare] => LIKE
                                )

                            [59] => Array
                                (
                                    [key] => agreement
                                    [value] => "9033"
                                    [compare] => LIKE
                                )

                            [relation] => OR
                        )

                    [relation] => OR
                    [meta_table] => wpry_postmeta
                    [meta_id_column] => post_id
                    [primary_table] => wpry_posts
                    [primary_id_column] => ID
                    [table_aliases:protected] => Array
                        (
                            [0] => wpry_postmeta
                        )

                    [clauses:protected] => Array
                        (
                            [wpry_postmeta] => Array
                                (
                                    [key] => agreement
                                    [value] => "1084"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-1] => Array
                                (
                                    [key] => agreement
                                    [value] => "1087"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-2] => Array
                                (
                                    [key] => agreement
                                    [value] => "12797"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-3] => Array
                                (
                                    [key] => agreement
                                    [value] => "1088"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-4] => Array
                                (
                                    [key] => agreement
                                    [value] => "1090"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-5] => Array
                                (
                                    [key] => agreement
                                    [value] => "1039"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-6] => Array
                                (
                                    [key] => agreement
                                    [value] => "4467"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-7] => Array
                                (
                                    [key] => agreement
                                    [value] => "4794"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-8] => Array
                                (
                                    [key] => agreement
                                    [value] => "11245"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-9] => Array
                                (
                                    [key] => agreement
                                    [value] => "3817"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-10] => Array
                                (
                                    [key] => agreement
                                    [value] => "9858"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-11] => Array
                                (
                                    [key] => agreement
                                    [value] => "9849"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-12] => Array
                                (
                                    [key] => agreement
                                    [value] => "4832"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-13] => Array
                                (
                                    [key] => agreement
                                    [value] => "13124"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-14] => Array
                                (
                                    [key] => agreement
                                    [value] => "11464"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-15] => Array
                                (
                                    [key] => agreement
                                    [value] => "3373"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-16] => Array
                                (
                                    [key] => agreement
                                    [value] => "1083"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-17] => Array
                                (
                                    [key] => agreement
                                    [value] => "1099"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-18] => Array
                                (
                                    [key] => agreement
                                    [value] => "12137"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-19] => Array
                                (
                                    [key] => agreement
                                    [value] => "12820"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-20] => Array
                                (
                                    [key] => agreement
                                    [value] => "12903"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-21] => Array
                                (
                                    [key] => agreement
                                    [value] => "11343"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-22] => Array
                                (
                                    [key] => agreement
                                    [value] => "12775"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-23] => Array
                                (
                                    [key] => agreement
                                    [value] => "1103"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-24] => Array
                                (
                                    [key] => agreement
                                    [value] => "3888"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-25] => Array
                                (
                                    [key] => agreement
                                    [value] => "12922"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-26] => Array
                                (
                                    [key] => agreement
                                    [value] => "12092"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-27] => Array
                                (
                                    [key] => agreement
                                    [value] => "11785"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-28] => Array
                                (
                                    [key] => agreement
                                    [value] => "11600"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-29] => Array
                                (
                                    [key] => agreement
                                    [value] => "11722"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-30] => Array
                                (
                                    [key] => agreement
                                    [value] => "3404"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-31] => Array
                                (
                                    [key] => agreement
                                    [value] => "1092"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-32] => Array
                                (
                                    [key] => agreement
                                    [value] => "11094"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-33] => Array
                                (
                                    [key] => agreement
                                    [value] => "5110"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-34] => Array
                                (
                                    [key] => agreement
                                    [value] => "12012"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-35] => Array
                                (
                                    [key] => agreement
                                    [value] => "3794"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-36] => Array
                                (
                                    [key] => agreement
                                    [value] => "4026"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-37] => Array
                                (
                                    [key] => agreement
                                    [value] => "1091"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-38] => Array
                                (
                                    [key] => agreement
                                    [value] => "11063"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-39] => Array
                                (
                                    [key] => agreement
                                    [value] => "11038"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-40] => Array
                                (
                                    [key] => agreement
                                    [value] => "11099"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-41] => Array
                                (
                                    [key] => agreement
                                    [value] => "11079"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-42] => Array
                                (
                                    [key] => agreement
                                    [value] => "11672"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-43] => Array
                                (
                                    [key] => agreement
                                    [value] => "12846"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-44] => Array
                                (
                                    [key] => agreement
                                    [value] => "12992"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-45] => Array
                                (
                                    [key] => agreement
                                    [value] => "2420"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-46] => Array
                                (
                                    [key] => agreement
                                    [value] => "5267"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-47] => Array
                                (
                                    [key] => agreement
                                    [value] => "12108"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-48] => Array
                                (
                                    [key] => agreement
                                    [value] => "11543"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-49] => Array
                                (
                                    [key] => agreement
                                    [value] => "12678"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-50] => Array
                                (
                                    [key] => agreement
                                    [value] => "11568"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-51] => Array
                                (
                                    [key] => agreement
                                    [value] => "11325"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-52] => Array
                                (
                                    [key] => agreement
                                    [value] => "1086"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-53] => Array
                                (
                                    [key] => agreement
                                    [value] => "13069"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-54] => Array
                                (
                                    [key] => agreement
                                    [value] => "4070"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-55] => Array
                                (
                                    [key] => agreement
                                    [value] => "12753"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-56] => Array
                                (
                                    [key] => agreement
                                    [value] => "1089"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-57] => Array
                                (
                                    [key] => agreement
                                    [value] => "12707"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-58] => Array
                                (
                                    [key] => agreement
                                    [value] => "12731"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                            [wpry_postmeta-59] => Array
                                (
                                    [key] => agreement
                                    [value] => "9033"
                                    [compare] => LIKE
                                    [compare_key] => =
                                    [alias] => wpry_postmeta
                                    [cast] => CHAR
                                )

                        )

                    [has_or_relation:protected] => 1
                )

            [date_query] => 
            [request] => SELECT   wpry_posts.*
					 FROM wpry_posts  LEFT JOIN wpry_term_relationships ON (wpry_posts.ID = wpry_term_relationships.object_id) INNER JOIN wpry_postmeta ON ( wpry_posts.ID = wpry_postmeta.post_id )
					 WHERE 1=1  AND ( 
  wpry_term_relationships.term_taxonomy_id IN (278)
) AND ( 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"1084\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"1087\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12797\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"1088\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"1090\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"1039\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"4467\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"4794\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11245\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"3817\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"9858\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"9849\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"4832\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"13124\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11464\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"3373\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"1083\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"1099\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12137\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12820\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12903\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11343\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12775\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"1103\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"3888\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12922\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12092\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11785\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11600\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11722\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"3404\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"1092\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11094\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"5110\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12012\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"3794\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"4026\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"1091\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11063\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11038\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11099\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11079\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11672\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12846\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12992\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"2420\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"5267\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12108\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11543\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12678\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11568\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"11325\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"1086\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"13069\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"4070\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12753\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"1089\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12707\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"12731\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' ) 
  OR 
  ( wpry_postmeta.meta_key = 'agreement' AND wpry_postmeta.meta_value LIKE '{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}\"9033\"{773abbf3d2279217872d494ed853393d252d51a9aa6888b2ca703003964da72f}' )
) AND ((wpry_posts.post_type = 'provision_document' AND (wpry_posts.post_status = 'publish' OR wpry_posts.post_status = 'acf-disabled')))
					 GROUP BY wpry_posts.ID
					 ORDER BY wpry_posts.post_date DESC
					 
            [posts] => Array
                (
                    [0] => WP_Post Object
                        (
                            [ID] => 13134
                            [post_author] => 5
                            [post_date] => 2025-10-23 11:26:05
                            [post_date_gmt] => 2025-10-23 11:26:05
                            [post_content] => 
                            [post_title] => Ferring - MPP, Post-Partum Hemorrhage Prevention & Treatment (Heat Stable Carbetocin) MOU
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => ferring-mpp-post-partum-hemorrhage-prevention-treatment-heat-stable-carbetocin-mou-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-10-23 12:07:40
                            [post_modified_gmt] => 2025-10-23 12:07:40
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=13134
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [1] => WP_Post Object
                        (
                            [ID] => 13080
                            [post_author] => 5
                            [post_date] => 2025-09-08 14:58:31
                            [post_date_gmt] => 2025-09-08 14:58:31
                            [post_content] => 
                            [post_title] => University of Michigan Template Therapeutics License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => university-of-michigan-template-therapeutics-license-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-09-09 08:08:13
                            [post_modified_gmt] => 2025-09-09 08:08:13
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=13080
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [2] => WP_Post Object
                        (
                            [ID] => 12933
                            [post_author] => 5
                            [post_date] => 2025-09-01 10:33:07
                            [post_date_gmt] => 2025-09-01 10:33:07
                            [post_content] => 
                            [post_title] => MIT - Visterra, Dengue Monoclonal Antibody Patent License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mit-visterra-dengue-monoclonal-antibody-patent-license-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-09-01 10:33:07
                            [post_modified_gmt] => 2025-09-01 10:33:07
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12933
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [3] => WP_Post Object
                        (
                            [ID] => 13004
                            [post_author] => 5
                            [post_date] => 2025-08-26 09:59:46
                            [post_date_gmt] => 2025-08-26 09:59:46
                            [post_content] => 
                            [post_title] => Public Health Agency of Canada (PHAC) - Bioprotection Systems Corp., Ebola Vaccine License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => public-health-agency-of-canada-phac-bioprotection-systems-corp-ebola-vaccine-license-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-08-26 10:22:02
                            [post_modified_gmt] => 2025-08-26 10:22:02
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=13004
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [4] => WP_Post Object
                        (
                            [ID] => 12914
                            [post_author] => 5
                            [post_date] => 2025-08-05 10:52:26
                            [post_date_gmt] => 2025-08-05 10:52:26
                            [post_content] => 
                            [post_title] => Johns Hopkins University – Aduro Biotech, Cancer Immunotherapy License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => johns-hopkins-university-aduro-biotech-cancer-immunotherapy-license-agreement-15
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-08-05 10:52:26
                            [post_modified_gmt] => 2025-08-05 10:52:26
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12914
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [5] => WP_Post Object
                        (
                            [ID] => 12858
                            [post_author] => 5
                            [post_date] => 2025-07-23 10:16:21
                            [post_date_gmt] => 2025-07-23 10:16:21
                            [post_content] => 
                            [post_title] => Protalix - Fiocruz, Gaucher Disease Therapy Technology Transfer and Supply Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => protalix-fiocruz-gaucher-disease-therapy-technology-transfer-and-supply-agreement-14
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-07-23 10:16:21
                            [post_modified_gmt] => 2025-07-23 10:16:21
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12858
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [6] => WP_Post Object
                        (
                            [ID] => 12829
                            [post_author] => 5
                            [post_date] => 2025-06-30 10:44:45
                            [post_date_gmt] => 2025-06-30 10:44:45
                            [post_content] => 
                            [post_title] => Harvard - Tectonic Therapeutic, License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => harvard-tectonic-therapeutic-license-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-06-30 10:44:45
                            [post_modified_gmt] => 2025-06-30 10:44:45
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12829
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [7] => WP_Post Object
                        (
                            [ID] => 12809
                            [post_author] => 5
                            [post_date] => 2025-06-26 07:31:27
                            [post_date_gmt] => 2025-06-26 07:31:27
                            [post_content] => 
                            [post_title] => Atreca - Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => atreca-gates-medical-research-institute-malaria-monoclonal-antibodies-license-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-06-26 08:45:41
                            [post_modified_gmt] => 2025-06-26 08:45:41
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12809
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [8] => WP_Post Object
                        (
                            [ID] => 12788
                            [post_author] => 5
                            [post_date] => 2025-06-18 11:04:12
                            [post_date_gmt] => 2025-06-18 11:04:12
                            [post_content] => 
                            [post_title] => MedinCell - MPP, Malaria Vector Control (mdc-STM/ivermectin formulation) License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => medincell-mpp-malaria-vector-control-mdc-stm-ivermectin-formulation-license-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-06-18 11:46:59
                            [post_modified_gmt] => 2025-06-18 11:46:59
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12788
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [9] => WP_Post Object
                        (
                            [ID] => 12764
                            [post_author] => 5
                            [post_date] => 2025-06-13 14:15:31
                            [post_date_gmt] => 2025-06-13 14:15:31
                            [post_content] => 
                            [post_title] => Valneva - Serum Institute of India, Chikungunya Vaccine License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => valneva-serum-institute-of-india-chikungunya-vaccine-license-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-06-13 14:15:31
                            [post_modified_gmt] => 2025-06-13 14:15:31
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12764
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [10] => WP_Post Object
                        (
                            [ID] => 12742
                            [post_author] => 5
                            [post_date] => 2025-05-27 14:12:31
                            [post_date_gmt] => 2025-05-27 14:12:31
                            [post_content] => 
                            [post_title] => Visterra - Serum Institute of India, Dengue Fever Therapeutic, License and Collaboration Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => visterra-serum-institute-of-india-dengue-fever-therapeutic-license-and-collaboration-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-09-01 12:21:55
                            [post_modified_gmt] => 2025-09-01 12:21:55
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12742
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [11] => WP_Post Object
                        (
                            [ID] => 12722
                            [post_author] => 5
                            [post_date] => 2025-05-22 08:55:29
                            [post_date_gmt] => 2025-05-22 08:55:29
                            [post_content] => 
                            [post_title] => ViiV - MPP, HIV Prevention Medicine (Cabotegravir LA for PrEP), License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => viiv-mpp-hiv-prevention-medicine-cabotegravir-la-for-prep-license-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-05-22 09:45:59
                            [post_modified_gmt] => 2025-05-22 09:45:59
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12722
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [12] => WP_Post Object
                        (
                            [ID] => 12472
                            [post_author] => 5
                            [post_date] => 2025-01-08 10:00:05
                            [post_date_gmt] => 2025-01-08 10:00:05
                            [post_content] => 
                            [post_title] => University of Liverpool – MPP, HIV Therapeutic Collaboration Agreement and Patent & Know-How License
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => university-of-liverpool-mpp-hiv-therapeutic-collaboration-agreement-and-patent-know-how-license-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2025-01-08 10:00:05
                            [post_modified_gmt] => 2025-01-08 10:00:05
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12472
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [13] => WP_Post Object
                        (
                            [ID] => 12395
                            [post_author] => 5
                            [post_date] => 2024-12-02 16:15:41
                            [post_date_gmt] => 2024-12-02 16:15:41
                            [post_content] => 
                            [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-12-06 15:28:17
                            [post_modified_gmt] => 2024-12-06 15:28:17
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12395
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [14] => WP_Post Object
                        (
                            [ID] => 12257
                            [post_author] => 5
                            [post_date] => 2024-11-05 14:41:55
                            [post_date_gmt] => 2024-11-05 14:41:55
                            [post_content] => 
                            [post_title] => AbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) Pediatric License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => abbvie-mpp-hiv-antiretroviral-lopinavir-ritonavir-lpv-r-pediatric-license-agreement-10
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-11-05 14:41:55
                            [post_modified_gmt] => 2024-11-05 14:41:55
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12257
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [15] => WP_Post Object
                        (
                            [ID] => 12215
                            [post_author] => 5
                            [post_date] => 2024-10-23 12:15:55
                            [post_date_gmt] => 2024-10-23 12:15:55
                            [post_content] => 
                            [post_title] => Gilead, HIV Therapeutic (Lenacapavir) Template License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => gilead-hiv-therapeutic-lenacapavir-template-license-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-10-23 12:15:55
                            [post_modified_gmt] => 2024-10-23 12:15:55
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12215
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [16] => WP_Post Object
                        (
                            [ID] => 12125
                            [post_author] => 5
                            [post_date] => 2024-10-17 09:06:21
                            [post_date_gmt] => 2024-10-17 09:06:21
                            [post_content] => 
                            [post_title] => Novartis – MPP, Nilotinib, Non-Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => novartis-mpp-nilotinib-non-exclusive-license-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-10-17 09:06:21
                            [post_modified_gmt] => 2024-10-17 09:06:21
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12125
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [17] => WP_Post Object
                        (
                            [ID] => 12104
                            [post_author] => 5
                            [post_date] => 2024-10-09 14:58:53
                            [post_date_gmt] => 2024-10-09 14:58:53
                            [post_content] => 
                            [post_title] => MPP - Biovac, mRNA Vaccine Technology Transfer Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-biovac-mrna-vaccine-technology-transfer-agreement-4
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-10-09 14:58:53
                            [post_modified_gmt] => 2024-10-09 14:58:53
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=12104
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [18] => WP_Post Object
                        (
                            [ID] => 11811
                            [post_author] => 5
                            [post_date] => 2024-05-30 14:58:02
                            [post_date_gmt] => 2024-05-30 14:58:02
                            [post_content] => 
                            [post_title] => Pfizer - MPP, TB Therapeutic (Sutezolid) Non-Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => pfizer-mpp-tb-therapeutic-sutezolid-non-exclusive-license-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-05-30 14:58:02
                            [post_modified_gmt] => 2024-05-30 14:58:02
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11811
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [19] => WP_Post Object
                        (
                            [ID] => 11795
                            [post_author] => 5
                            [post_date] => 2024-05-30 10:00:01
                            [post_date_gmt] => 2024-05-30 10:00:01
                            [post_content] => 
                            [post_title] => MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-gates-medical-research-institute-tb-therapeutic-sutezolid-sublicense-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-05-30 10:18:27
                            [post_modified_gmt] => 2024-05-30 10:18:27
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11795
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [20] => WP_Post Object
                        (
                            [ID] => 11680
                            [post_author] => 5
                            [post_date] => 2024-03-27 08:23:18
                            [post_date_gmt] => 2024-03-27 08:23:18
                            [post_content] => 
                            [post_title] => Population Council - TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => population-council-therapeuticsmd-nestorone-contraceptive-ring-license-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-03-27 08:23:18
                            [post_modified_gmt] => 2024-03-27 08:23:18
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11680
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [21] => WP_Post Object
                        (
                            [ID] => 11613
                            [post_author] => 5
                            [post_date] => 2024-01-25 09:08:27
                            [post_date_gmt] => 2024-01-25 09:08:27
                            [post_content] => 
                            [post_title] => MPP (C-TAP) – Biotech Africa, COVID-19 Diagnostic, Patent & Material Sublicense Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-c-tap-biotech-africa-covid-19-diagnostic-patent-material-sublicense-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-01-25 09:08:27
                            [post_modified_gmt] => 2024-01-25 09:08:27
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11613
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [22] => WP_Post Object
                        (
                            [ID] => 11579
                            [post_author] => 5
                            [post_date] => 2023-12-21 11:09:11
                            [post_date_gmt] => 2023-12-21 11:09:11
                            [post_content] => 
                            [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-21 11:09:55
                            [post_modified_gmt] => 2023-12-21 11:09:55
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11579
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [23] => WP_Post Object
                        (
                            [ID] => 11556
                            [post_author] => 5
                            [post_date] => 2023-12-01 14:27:32
                            [post_date_gmt] => 2023-12-01 14:27:32
                            [post_content] => 
                            [post_title] => UC Berkeley, Therapeutics & Diagnostics, Exclusive License Agreement Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => uc-berkeley-therapeutics-diagnostics-exclusive-license-agreement-template-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-12-01 14:27:32
                            [post_modified_gmt] => 2023-12-01 14:27:32
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11556
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [24] => WP_Post Object
                        (
                            [ID] => 11479
                            [post_author] => 5
                            [post_date] => 2023-11-20 09:20:32
                            [post_date_gmt] => 2023-11-20 09:20:32
                            [post_content] => 
                            [post_title] => GARDP – Orchid, Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => gardp-orchid-cefiderocol-manufacturing-sublicense-and-technology-transfer-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-11-20 09:20:32
                            [post_modified_gmt] => 2023-11-20 09:20:32
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11479
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [25] => WP_Post Object
                        (
                            [ID] => 11354
                            [post_author] => 5
                            [post_date] => 2023-10-11 12:48:35
                            [post_date_gmt] => 2023-10-11 12:48:35
                            [post_content] => 
                            [post_title] => Medigen - MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => mpp-c-tap-medigen-covid-19-vaccine-patent-and-know-how-license-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-10-11 15:52:44
                            [post_modified_gmt] => 2023-10-11 15:52:44
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11354
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [26] => WP_Post Object
                        (
                            [ID] => 11334
                            [post_author] => 5
                            [post_date] => 2023-09-26 12:20:43
                            [post_date_gmt] => 2023-09-26 12:20:43
                            [post_content] => 
                            [post_title] => University of Chile – MPP (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => university-of-chile-mpp-c-tap-covid-19-diagnostic-material-know-how-license-agreement-7
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-27 09:17:25
                            [post_modified_gmt] => 2023-09-27 09:17:25
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11334
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [27] => WP_Post Object
                        (
                            [ID] => 11257
                            [post_author] => 5
                            [post_date] => 2023-09-18 10:52:07
                            [post_date_gmt] => 2023-09-18 10:52:07
                            [post_content] => 
                            [post_title] => CSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => csic-mpp-c-tap-covid-19-vaccine-patent-and-material-license-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-18 11:52:21
                            [post_modified_gmt] => 2023-09-18 11:52:21
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11257
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [28] => WP_Post Object
                        (
                            [ID] => 11134
                            [post_author] => 5
                            [post_date] => 2023-09-04 13:43:48
                            [post_date_gmt] => 2023-09-04 13:43:48
                            [post_content] => 
                            [post_title] => NIH – UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => nih-uniqure-aav5-gene-therapies-exclusive-and-non-exclusive-license-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-04 13:43:48
                            [post_modified_gmt] => 2023-09-04 13:43:48
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11134
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [29] => WP_Post Object
                        (
                            [ID] => 11124
                            [post_author] => 5
                            [post_date] => 2023-09-04 10:26:26
                            [post_date_gmt] => 2023-09-04 10:26:26
                            [post_content] => 
                            [post_title] => PHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => phs-nih-cdc-fda-model-exclusive-patent-license-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-04 10:26:26
                            [post_modified_gmt] => 2023-09-04 10:26:26
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11124
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [30] => WP_Post Object
                        (
                            [ID] => 11093
                            [post_author] => 5
                            [post_date] => 2023-08-30 15:21:05
                            [post_date_gmt] => 2023-08-30 15:21:05
                            [post_content] => 
                            [post_title] => PHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => phs-nih-cdc-fda-model-non-exclusive-patent-license-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-08-30 15:21:05
                            [post_modified_gmt] => 2023-08-30 15:21:05
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11093
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [31] => WP_Post Object
                        (
                            [ID] => 11078
                            [post_author] => 5
                            [post_date] => 2023-08-29 08:34:35
                            [post_date_gmt] => 2023-08-29 08:34:35
                            [post_content] => 
                            [post_title] => PHS - Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => phs-aridis-rotavirus-vaccine-exclusive-and-non-exclusive-license-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-08-29 08:34:35
                            [post_modified_gmt] => 2023-08-29 08:34:35
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11078
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [32] => WP_Post Object
                        (
                            [ID] => 11061
                            [post_author] => 5
                            [post_date] => 2023-08-25 08:44:53
                            [post_date_gmt] => 2023-08-25 08:44:53
                            [post_content] => 
                            [post_title] => PHS - Biosyn, HIV Prophylactic Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => phs-biosyn-hiv-prophylactic-exclusive-licence-agreement-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-08-28 08:18:03
                            [post_modified_gmt] => 2023-08-28 08:18:03
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=11061
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [33] => WP_Post Object
                        (
                            [ID] => 9875
                            [post_author] => 5
                            [post_date] => 2023-04-19 10:41:01
                            [post_date_gmt] => 2023-04-19 10:41:01
                            [post_content] => 
                            [post_title] => DNDi Template Development Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-development-collaboration-and-license-agreement-3
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 11:59:40
                            [post_modified_gmt] => 2023-06-27 11:59:40
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9875
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [34] => WP_Post Object
                        (
                            [ID] => 9861
                            [post_author] => 5
                            [post_date] => 2023-04-17 14:18:47
                            [post_date_gmt] => 2023-04-17 14:18:47
                            [post_content] => 
                            [post_title] => DNDi Template Research Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => dndi-template-research-collaboration-and-license-agreement
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-27 13:48:20
                            [post_modified_gmt] => 2023-06-27 13:48:20
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9861
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [35] => WP_Post Object
                        (
                            [ID] => 9057
                            [post_author] => 5
                            [post_date] => 2023-03-06 10:34:15
                            [post_date_gmt] => 2023-03-06 10:34:15
                            [post_content] => 
                            [post_title] => Yale University - BIND Biosciences, Cancer Therapeutic, Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => bind-biosciences-inc-yale-university-cancer-therapeutic-exclusive-license-agreement-13
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-11-30 12:33:17
                            [post_modified_gmt] => 2023-11-30 12:33:17
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=9057
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [36] => WP_Post Object
                        (
                            [ID] => 5806
                            [post_author] => 5
                            [post_date] => 2022-09-28 14:56:08
                            [post_date_gmt] => 2022-09-28 14:56:08
                            [post_content] => 
                            [post_title] => Gilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => gilead-mpp-arene-lifesciences-hiv-therapeutic-license-agreement-8
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-19 14:34:20
                            [post_modified_gmt] => 2024-09-19 14:34:20
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5806
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [37] => WP_Post Object
                        (
                            [ID] => 5280
                            [post_author] => 5
                            [post_date] => 2022-07-08 11:46:11
                            [post_date_gmt] => 2022-07-08 11:46:11
                            [post_content] => 
                            [post_title] => Shionogi – GARDP, Cefiderocol License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => shionogi-gardp-cefiderocol-license-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-23 12:07:46
                            [post_modified_gmt] => 2024-09-23 12:07:46
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5280
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [38] => WP_Post Object
                        (
                            [ID] => 5122
                            [post_author] => 5
                            [post_date] => 2022-06-29 14:42:34
                            [post_date_gmt] => 2022-06-29 14:42:34
                            [post_content] => 
                            [post_title] => NIH – MPP (C-TAP), COVID-19 Technologies, Patent and Biological Material License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => 5122
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 14:03:18
                            [post_modified_gmt] => 2024-09-20 14:03:18
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=5122
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [39] => WP_Post Object
                        (
                            [ID] => 4868
                            [post_author] => 5
                            [post_date] => 2022-06-07 09:30:21
                            [post_date_gmt] => 2022-06-07 09:30:21
                            [post_content] => 
                            [post_title] => Boston University Startup Exclusive License Template
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => boston-university-startup-exclusive-license-template-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-20 12:32:18
                            [post_modified_gmt] => 2023-06-20 12:32:18
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4868
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [40] => WP_Post Object
                        (
                            [ID] => 4850
                            [post_author] => 5
                            [post_date] => 2022-05-31 10:27:15
                            [post_date_gmt] => 2022-05-31 10:27:15
                            [post_content] => 
                            [post_title] => Elkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => elkurt-ocean-biomedical-malaria-vaccine-exclusive-license-agreement-16
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-08 13:10:55
                            [post_modified_gmt] => 2024-04-08 13:10:55
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4850
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [41] => WP_Post Object
                        (
                            [ID] => 4806
                            [post_author] => 5
                            [post_date] => 2022-05-24 08:59:08
                            [post_date_gmt] => 2022-05-24 08:59:08
                            [post_content] => 
                            [post_title] => CSIC - MPP (C-TAP), COVID-19 Diagnostic, Patent & Material License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => csic-mpp-covid-19-antibody-diagnostic-patent-material-license-agreement-9
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-27 10:11:24
                            [post_modified_gmt] => 2023-09-27 10:11:24
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4806
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [42] => WP_Post Object
                        (
                            [ID] => 4490
                            [post_author] => 5
                            [post_date] => 2022-03-17 15:37:26
                            [post_date_gmt] => 2022-03-17 15:37:26
                            [post_content] => 
                            [post_title] => Cellscript – BioNTech mRNA Technology Patent Sublicense
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => cellscript-biontech-mrna-technology-patent-sublicense-11
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-06-21 09:05:15
                            [post_modified_gmt] => 2023-06-21 09:05:15
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4490
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [43] => WP_Post Object
                        (
                            [ID] => 4079
                            [post_author] => 5
                            [post_date] => 2022-01-11 08:07:49
                            [post_date_gmt] => 2022-01-11 08:07:49
                            [post_content] => 
                            [post_title] => University of Washington – MPP, Long-acting Injectable HIV Treatment License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => university-of-washington-medicines-patent-pool-long-acting-injectable-hiv-treatment-license-agreement-6
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-04-12 12:51:06
                            [post_modified_gmt] => 2024-04-12 12:51:06
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4079
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [44] => WP_Post Object
                        (
                            [ID] => 4051
                            [post_author] => 5
                            [post_date] => 2022-01-03 11:01:41
                            [post_date_gmt] => 2022-01-03 11:01:41
                            [post_content] => 
                            [post_title] => Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => ocugen-bbil-covid-19-vaccine-covaxin-co-development-supply-commercialization-agreement-17
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 14:25:43
                            [post_modified_gmt] => 2024-09-20 14:25:43
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4051
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [45] => WP_Post Object
                        (
                            [ID] => 4009
                            [post_author] => 5
                            [post_date] => 2021-12-14 15:10:51
                            [post_date_gmt] => 2021-12-14 15:10:51
                            [post_content] => 
                            [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => curevac-and-gsk-collaboration-and-license-agreement-2
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-09-27 11:47:52
                            [post_modified_gmt] => 2023-09-27 11:47:52
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=4009
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [46] => WP_Post Object
                        (
                            [ID] => 3909
                            [post_author] => 5
                            [post_date] => 2021-11-22 13:29:28
                            [post_date_gmt] => 2021-11-22 13:29:28
                            [post_content] => 
                            [post_title] => Merck – MPP, Molnupiravir License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => msd-mpp-molnupiravir-license-agreement-17
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2024-09-20 08:09:59
                            [post_modified_gmt] => 2024-09-20 08:09:59
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=3909
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [47] => WP_Post Object
                        (
                            [ID] => 3810
                            [post_author] => 5
                            [post_date] => 2021-09-10 12:21:33
                            [post_date_gmt] => 2021-09-10 12:21:33
                            [post_content] => 
                            [post_title] => Novavax - Serum Institute of India, COVID-19 Vaccine Supply and License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => novavax-serum-institute-of-india-covid-19-vaccine-supply-and-license-agreement-15
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-07-10 14:55:36
                            [post_modified_gmt] => 2023-07-10 14:55:36
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=3810
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                    [48] => WP_Post Object
                        (
                            [ID] => 3418
                            [post_author] => 5
                            [post_date] => 2021-06-30 19:06:19
                            [post_date_gmt] => 2021-06-30 19:06:19
                            [post_content] => 
                            [post_title] => NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement
                            [post_excerpt] => 
                            [post_status] => publish
                            [comment_status] => closed
                            [ping_status] => closed
                            [post_password] => 
                            [post_name] => nih-geovax-non-exclusive-patent-and-biological-materials-license-agreement-12
                            [to_ping] => 
                            [pinged] => 
                            [post_modified] => 2023-08-30 15:19:00
                            [post_modified_gmt] => 2023-08-30 15:19:00
                            [post_content_filtered] => 
                            [post_parent] => 0
                            [guid] => https://ghiaa.org/?post_type=provision_document&p=3418
                            [menu_order] => 0
                            [post_type] => provision_document
                            [post_mime_type] => 
                            [comment_count] => 0
                            [filter] => raw
                        )

                )

            [post_count] => 49
            [current_post] => -1
            [before_loop] => 1
            [in_the_loop] => 
            [post] => WP_Post Object
                (
                    [ID] => 13134
                    [post_author] => 5
                    [post_date] => 2025-10-23 11:26:05
                    [post_date_gmt] => 2025-10-23 11:26:05
                    [post_content] => 
                    [post_title] => Ferring - MPP, Post-Partum Hemorrhage Prevention & Treatment (Heat Stable Carbetocin) MOU
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => ferring-mpp-post-partum-hemorrhage-prevention-treatment-heat-stable-carbetocin-mou-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-10-23 12:07:40
                    [post_modified_gmt] => 2025-10-23 12:07:40
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=13134
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [comment_count] => 0
            [current_comment] => -1
            [found_posts] => 49
            [max_num_pages] => 0
            [max_num_comment_pages] => 0
            [is_single] => 
            [is_preview] => 
            [is_page] => 
            [is_archive] => 1
            [is_date] => 
            [is_year] => 
            [is_month] => 
            [is_day] => 
            [is_time] => 
            [is_author] => 
            [is_category] => 
            [is_tag] => 
            [is_tax] => 1
            [is_search] => 
            [is_feed] => 
            [is_comment_feed] => 
            [is_trackback] => 
            [is_home] => 
            [is_privacy_policy] => 
            [is_404] => 
            [is_embed] => 
            [is_paged] => 
            [is_admin] => 
            [is_attachment] => 
            [is_singular] => 
            [is_robots] => 
            [is_favicon] => 
            [is_posts_page] => 
            [is_post_type_archive] => 1
            [query_vars_hash:WP_Query:private] => 9f91c1adae061e79a664526cbe580758
            [query_vars_changed:WP_Query:private] => 
            [thumbnails_cached] => 
            [allow_query_attachment_by_filename:protected] => 
            [stopwords:WP_Query:private] => 
            [compat_fields:WP_Query:private] => Array
                (
                    [0] => query_vars_hash
                    [1] => query_vars_changed
                )

            [compat_methods:WP_Query:private] => Array
                (
                    [0] => init_query_flags
                    [1] => parse_tax_query
                )

            [query_cache_key:WP_Query:private] => wp_query:552d55e196c79e9e9d357de967338213
        )

    [text_agreement_q_rslts] => 
    [text_provision_q_rslts] => 
    [provisions] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 13134
                    [post_author] => 5
                    [post_date] => 2025-10-23 11:26:05
                    [post_date_gmt] => 2025-10-23 11:26:05
                    [post_content] => 
                    [post_title] => Ferring - MPP, Post-Partum Hemorrhage Prevention & Treatment (Heat Stable Carbetocin) MOU
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => ferring-mpp-post-partum-hemorrhage-prevention-treatment-heat-stable-carbetocin-mou-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-10-23 12:07:40
                    [post_modified_gmt] => 2025-10-23 12:07:40
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=13134
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [1] => WP_Post Object
                (
                    [ID] => 13080
                    [post_author] => 5
                    [post_date] => 2025-09-08 14:58:31
                    [post_date_gmt] => 2025-09-08 14:58:31
                    [post_content] => 
                    [post_title] => University of Michigan Template Therapeutics License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => university-of-michigan-template-therapeutics-license-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-09-09 08:08:13
                    [post_modified_gmt] => 2025-09-09 08:08:13
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=13080
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [2] => WP_Post Object
                (
                    [ID] => 12933
                    [post_author] => 5
                    [post_date] => 2025-09-01 10:33:07
                    [post_date_gmt] => 2025-09-01 10:33:07
                    [post_content] => 
                    [post_title] => MIT - Visterra, Dengue Monoclonal Antibody Patent License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => mit-visterra-dengue-monoclonal-antibody-patent-license-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-09-01 10:33:07
                    [post_modified_gmt] => 2025-09-01 10:33:07
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12933
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [3] => WP_Post Object
                (
                    [ID] => 13004
                    [post_author] => 5
                    [post_date] => 2025-08-26 09:59:46
                    [post_date_gmt] => 2025-08-26 09:59:46
                    [post_content] => 
                    [post_title] => Public Health Agency of Canada (PHAC) - Bioprotection Systems Corp., Ebola Vaccine License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => public-health-agency-of-canada-phac-bioprotection-systems-corp-ebola-vaccine-license-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-08-26 10:22:02
                    [post_modified_gmt] => 2025-08-26 10:22:02
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=13004
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [4] => WP_Post Object
                (
                    [ID] => 12914
                    [post_author] => 5
                    [post_date] => 2025-08-05 10:52:26
                    [post_date_gmt] => 2025-08-05 10:52:26
                    [post_content] => 
                    [post_title] => Johns Hopkins University – Aduro Biotech, Cancer Immunotherapy License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => johns-hopkins-university-aduro-biotech-cancer-immunotherapy-license-agreement-15
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-08-05 10:52:26
                    [post_modified_gmt] => 2025-08-05 10:52:26
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12914
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [5] => WP_Post Object
                (
                    [ID] => 12858
                    [post_author] => 5
                    [post_date] => 2025-07-23 10:16:21
                    [post_date_gmt] => 2025-07-23 10:16:21
                    [post_content] => 
                    [post_title] => Protalix - Fiocruz, Gaucher Disease Therapy Technology Transfer and Supply Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => protalix-fiocruz-gaucher-disease-therapy-technology-transfer-and-supply-agreement-14
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-07-23 10:16:21
                    [post_modified_gmt] => 2025-07-23 10:16:21
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12858
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [6] => WP_Post Object
                (
                    [ID] => 12829
                    [post_author] => 5
                    [post_date] => 2025-06-30 10:44:45
                    [post_date_gmt] => 2025-06-30 10:44:45
                    [post_content] => 
                    [post_title] => Harvard - Tectonic Therapeutic, License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => harvard-tectonic-therapeutic-license-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-06-30 10:44:45
                    [post_modified_gmt] => 2025-06-30 10:44:45
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12829
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [7] => WP_Post Object
                (
                    [ID] => 12809
                    [post_author] => 5
                    [post_date] => 2025-06-26 07:31:27
                    [post_date_gmt] => 2025-06-26 07:31:27
                    [post_content] => 
                    [post_title] => Atreca - Gates Medical Research Institute, Malaria Monoclonal Antibodies License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => atreca-gates-medical-research-institute-malaria-monoclonal-antibodies-license-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-06-26 08:45:41
                    [post_modified_gmt] => 2025-06-26 08:45:41
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12809
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [8] => WP_Post Object
                (
                    [ID] => 12788
                    [post_author] => 5
                    [post_date] => 2025-06-18 11:04:12
                    [post_date_gmt] => 2025-06-18 11:04:12
                    [post_content] => 
                    [post_title] => MedinCell - MPP, Malaria Vector Control (mdc-STM/ivermectin formulation) License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => medincell-mpp-malaria-vector-control-mdc-stm-ivermectin-formulation-license-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-06-18 11:46:59
                    [post_modified_gmt] => 2025-06-18 11:46:59
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12788
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [9] => WP_Post Object
                (
                    [ID] => 12764
                    [post_author] => 5
                    [post_date] => 2025-06-13 14:15:31
                    [post_date_gmt] => 2025-06-13 14:15:31
                    [post_content] => 
                    [post_title] => Valneva - Serum Institute of India, Chikungunya Vaccine License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => valneva-serum-institute-of-india-chikungunya-vaccine-license-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-06-13 14:15:31
                    [post_modified_gmt] => 2025-06-13 14:15:31
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12764
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [10] => WP_Post Object
                (
                    [ID] => 12742
                    [post_author] => 5
                    [post_date] => 2025-05-27 14:12:31
                    [post_date_gmt] => 2025-05-27 14:12:31
                    [post_content] => 
                    [post_title] => Visterra - Serum Institute of India, Dengue Fever Therapeutic, License and Collaboration Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => visterra-serum-institute-of-india-dengue-fever-therapeutic-license-and-collaboration-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-09-01 12:21:55
                    [post_modified_gmt] => 2025-09-01 12:21:55
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12742
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [11] => WP_Post Object
                (
                    [ID] => 12722
                    [post_author] => 5
                    [post_date] => 2025-05-22 08:55:29
                    [post_date_gmt] => 2025-05-22 08:55:29
                    [post_content] => 
                    [post_title] => ViiV - MPP, HIV Prevention Medicine (Cabotegravir LA for PrEP), License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => viiv-mpp-hiv-prevention-medicine-cabotegravir-la-for-prep-license-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-05-22 09:45:59
                    [post_modified_gmt] => 2025-05-22 09:45:59
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12722
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [12] => WP_Post Object
                (
                    [ID] => 12472
                    [post_author] => 5
                    [post_date] => 2025-01-08 10:00:05
                    [post_date_gmt] => 2025-01-08 10:00:05
                    [post_content] => 
                    [post_title] => University of Liverpool – MPP, HIV Therapeutic Collaboration Agreement and Patent & Know-How License
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => university-of-liverpool-mpp-hiv-therapeutic-collaboration-agreement-and-patent-know-how-license-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2025-01-08 10:00:05
                    [post_modified_gmt] => 2025-01-08 10:00:05
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12472
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [13] => WP_Post Object
                (
                    [ID] => 12395
                    [post_author] => 5
                    [post_date] => 2024-12-02 16:15:41
                    [post_date_gmt] => 2024-12-02 16:15:41
                    [post_content] => 
                    [post_title] => Spinal Muscular Atrophy Foundation - PTC Therapeutics, Spinal Muscular Atrophy Therapeutics Sponsored Research Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => spinal-muscular-atrophy-foundation-ptc-therapeutics-spinal-muscular-atrophy-therapeutics-sponsored-research-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-12-06 15:28:17
                    [post_modified_gmt] => 2024-12-06 15:28:17
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12395
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [14] => WP_Post Object
                (
                    [ID] => 12257
                    [post_author] => 5
                    [post_date] => 2024-11-05 14:41:55
                    [post_date_gmt] => 2024-11-05 14:41:55
                    [post_content] => 
                    [post_title] => AbbVie – MPP, HIV Antiretroviral (lopinavir, ritonavir – LPV/r) Pediatric License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => abbvie-mpp-hiv-antiretroviral-lopinavir-ritonavir-lpv-r-pediatric-license-agreement-10
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-11-05 14:41:55
                    [post_modified_gmt] => 2024-11-05 14:41:55
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12257
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [15] => WP_Post Object
                (
                    [ID] => 12215
                    [post_author] => 5
                    [post_date] => 2024-10-23 12:15:55
                    [post_date_gmt] => 2024-10-23 12:15:55
                    [post_content] => 
                    [post_title] => Gilead, HIV Therapeutic (Lenacapavir) Template License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => gilead-hiv-therapeutic-lenacapavir-template-license-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-10-23 12:15:55
                    [post_modified_gmt] => 2024-10-23 12:15:55
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12215
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [16] => WP_Post Object
                (
                    [ID] => 12125
                    [post_author] => 5
                    [post_date] => 2024-10-17 09:06:21
                    [post_date_gmt] => 2024-10-17 09:06:21
                    [post_content] => 
                    [post_title] => Novartis – MPP, Nilotinib, Non-Exclusive License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => novartis-mpp-nilotinib-non-exclusive-license-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-10-17 09:06:21
                    [post_modified_gmt] => 2024-10-17 09:06:21
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12125
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [17] => WP_Post Object
                (
                    [ID] => 12104
                    [post_author] => 5
                    [post_date] => 2024-10-09 14:58:53
                    [post_date_gmt] => 2024-10-09 14:58:53
                    [post_content] => 
                    [post_title] => MPP - Biovac, mRNA Vaccine Technology Transfer Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => mpp-biovac-mrna-vaccine-technology-transfer-agreement-4
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-10-09 14:58:53
                    [post_modified_gmt] => 2024-10-09 14:58:53
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=12104
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [18] => WP_Post Object
                (
                    [ID] => 11811
                    [post_author] => 5
                    [post_date] => 2024-05-30 14:58:02
                    [post_date_gmt] => 2024-05-30 14:58:02
                    [post_content] => 
                    [post_title] => Pfizer - MPP, TB Therapeutic (Sutezolid) Non-Exclusive License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => pfizer-mpp-tb-therapeutic-sutezolid-non-exclusive-license-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-05-30 14:58:02
                    [post_modified_gmt] => 2024-05-30 14:58:02
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11811
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [19] => WP_Post Object
                (
                    [ID] => 11795
                    [post_author] => 5
                    [post_date] => 2024-05-30 10:00:01
                    [post_date_gmt] => 2024-05-30 10:00:01
                    [post_content] => 
                    [post_title] => MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => mpp-gates-medical-research-institute-tb-therapeutic-sutezolid-sublicense-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-05-30 10:18:27
                    [post_modified_gmt] => 2024-05-30 10:18:27
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11795
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [20] => WP_Post Object
                (
                    [ID] => 11680
                    [post_author] => 5
                    [post_date] => 2024-03-27 08:23:18
                    [post_date_gmt] => 2024-03-27 08:23:18
                    [post_content] => 
                    [post_title] => Population Council - TherapeuticsMD, Nestorone Contraceptive Ring, License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => population-council-therapeuticsmd-nestorone-contraceptive-ring-license-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-03-27 08:23:18
                    [post_modified_gmt] => 2024-03-27 08:23:18
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11680
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [21] => WP_Post Object
                (
                    [ID] => 11613
                    [post_author] => 5
                    [post_date] => 2024-01-25 09:08:27
                    [post_date_gmt] => 2024-01-25 09:08:27
                    [post_content] => 
                    [post_title] => MPP (C-TAP) – Biotech Africa, COVID-19 Diagnostic, Patent & Material Sublicense Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => mpp-c-tap-biotech-africa-covid-19-diagnostic-patent-material-sublicense-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-01-25 09:08:27
                    [post_modified_gmt] => 2024-01-25 09:08:27
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11613
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [22] => WP_Post Object
                (
                    [ID] => 11579
                    [post_author] => 5
                    [post_date] => 2023-12-21 11:09:11
                    [post_date_gmt] => 2023-12-21 11:09:11
                    [post_content] => 
                    [post_title] => UK Medical Research Council - Indevus Pharmaceuticals, Antiviral Microbicide, Collaborative Research and Licensing Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uk-medical-research-council-indevus-pharmaceuticals-antiviral-microbicide-collaborative-research-and-licensing-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-21 11:09:55
                    [post_modified_gmt] => 2023-12-21 11:09:55
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11579
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [23] => WP_Post Object
                (
                    [ID] => 11556
                    [post_author] => 5
                    [post_date] => 2023-12-01 14:27:32
                    [post_date_gmt] => 2023-12-01 14:27:32
                    [post_content] => 
                    [post_title] => UC Berkeley, Therapeutics & Diagnostics, Exclusive License Agreement Template
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => uc-berkeley-therapeutics-diagnostics-exclusive-license-agreement-template-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-12-01 14:27:32
                    [post_modified_gmt] => 2023-12-01 14:27:32
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11556
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [24] => WP_Post Object
                (
                    [ID] => 11479
                    [post_author] => 5
                    [post_date] => 2023-11-20 09:20:32
                    [post_date_gmt] => 2023-11-20 09:20:32
                    [post_content] => 
                    [post_title] => GARDP – Orchid, Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => gardp-orchid-cefiderocol-manufacturing-sublicense-and-technology-transfer-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-11-20 09:20:32
                    [post_modified_gmt] => 2023-11-20 09:20:32
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11479
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [25] => WP_Post Object
                (
                    [ID] => 11354
                    [post_author] => 5
                    [post_date] => 2023-10-11 12:48:35
                    [post_date_gmt] => 2023-10-11 12:48:35
                    [post_content] => 
                    [post_title] => Medigen - MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => mpp-c-tap-medigen-covid-19-vaccine-patent-and-know-how-license-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-10-11 15:52:44
                    [post_modified_gmt] => 2023-10-11 15:52:44
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11354
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [26] => WP_Post Object
                (
                    [ID] => 11334
                    [post_author] => 5
                    [post_date] => 2023-09-26 12:20:43
                    [post_date_gmt] => 2023-09-26 12:20:43
                    [post_content] => 
                    [post_title] => University of Chile – MPP (C-TAP), COVID-19 Diagnostic Material & Know-How License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => university-of-chile-mpp-c-tap-covid-19-diagnostic-material-know-how-license-agreement-7
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-27 09:17:25
                    [post_modified_gmt] => 2023-09-27 09:17:25
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11334
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [27] => WP_Post Object
                (
                    [ID] => 11257
                    [post_author] => 5
                    [post_date] => 2023-09-18 10:52:07
                    [post_date_gmt] => 2023-09-18 10:52:07
                    [post_content] => 
                    [post_title] => CSIC – MPP (C-TAP), COVID-19 Vaccine, Patent and Material License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => csic-mpp-c-tap-covid-19-vaccine-patent-and-material-license-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-18 11:52:21
                    [post_modified_gmt] => 2023-09-18 11:52:21
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11257
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [28] => WP_Post Object
                (
                    [ID] => 11134
                    [post_author] => 5
                    [post_date] => 2023-09-04 13:43:48
                    [post_date_gmt] => 2023-09-04 13:43:48
                    [post_content] => 
                    [post_title] => NIH – UniQure, AAV5 Gene Therapies Exclusive and Non-Exclusive License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => nih-uniqure-aav5-gene-therapies-exclusive-and-non-exclusive-license-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-04 13:43:48
                    [post_modified_gmt] => 2023-09-04 13:43:48
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11134
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [29] => WP_Post Object
                (
                    [ID] => 11124
                    [post_author] => 5
                    [post_date] => 2023-09-04 10:26:26
                    [post_date_gmt] => 2023-09-04 10:26:26
                    [post_content] => 
                    [post_title] => PHS (NIH/CDC/FDA), Model Exclusive Patent License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => phs-nih-cdc-fda-model-exclusive-patent-license-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-04 10:26:26
                    [post_modified_gmt] => 2023-09-04 10:26:26
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11124
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [30] => WP_Post Object
                (
                    [ID] => 11093
                    [post_author] => 5
                    [post_date] => 2023-08-30 15:21:05
                    [post_date_gmt] => 2023-08-30 15:21:05
                    [post_content] => 
                    [post_title] => PHS (NIH/CDC/FDA), Model Non-Exclusive Patent License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => phs-nih-cdc-fda-model-non-exclusive-patent-license-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-08-30 15:21:05
                    [post_modified_gmt] => 2023-08-30 15:21:05
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11093
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [31] => WP_Post Object
                (
                    [ID] => 11078
                    [post_author] => 5
                    [post_date] => 2023-08-29 08:34:35
                    [post_date_gmt] => 2023-08-29 08:34:35
                    [post_content] => 
                    [post_title] => PHS - Aridis, Rotavirus Vaccine Exclusive and Non-Exclusive License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => phs-aridis-rotavirus-vaccine-exclusive-and-non-exclusive-license-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-08-29 08:34:35
                    [post_modified_gmt] => 2023-08-29 08:34:35
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11078
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [32] => WP_Post Object
                (
                    [ID] => 11061
                    [post_author] => 5
                    [post_date] => 2023-08-25 08:44:53
                    [post_date_gmt] => 2023-08-25 08:44:53
                    [post_content] => 
                    [post_title] => PHS - Biosyn, HIV Prophylactic Exclusive License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => phs-biosyn-hiv-prophylactic-exclusive-licence-agreement-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-08-28 08:18:03
                    [post_modified_gmt] => 2023-08-28 08:18:03
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=11061
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [33] => WP_Post Object
                (
                    [ID] => 9875
                    [post_author] => 5
                    [post_date] => 2023-04-19 10:41:01
                    [post_date_gmt] => 2023-04-19 10:41:01
                    [post_content] => 
                    [post_title] => DNDi Template Development Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-development-collaboration-and-license-agreement-3
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 11:59:40
                    [post_modified_gmt] => 2023-06-27 11:59:40
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9875
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [34] => WP_Post Object
                (
                    [ID] => 9861
                    [post_author] => 5
                    [post_date] => 2023-04-17 14:18:47
                    [post_date_gmt] => 2023-04-17 14:18:47
                    [post_content] => 
                    [post_title] => DNDi Template Research Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => dndi-template-research-collaboration-and-license-agreement
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-27 13:48:20
                    [post_modified_gmt] => 2023-06-27 13:48:20
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9861
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [35] => WP_Post Object
                (
                    [ID] => 9057
                    [post_author] => 5
                    [post_date] => 2023-03-06 10:34:15
                    [post_date_gmt] => 2023-03-06 10:34:15
                    [post_content] => 
                    [post_title] => Yale University - BIND Biosciences, Cancer Therapeutic, Exclusive License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => bind-biosciences-inc-yale-university-cancer-therapeutic-exclusive-license-agreement-13
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-11-30 12:33:17
                    [post_modified_gmt] => 2023-11-30 12:33:17
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=9057
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [36] => WP_Post Object
                (
                    [ID] => 5806
                    [post_author] => 5
                    [post_date] => 2022-09-28 14:56:08
                    [post_date_gmt] => 2022-09-28 14:56:08
                    [post_content] => 
                    [post_title] => Gilead – MPP – Arene Lifesciences, HIV Therapeutic License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => gilead-mpp-arene-lifesciences-hiv-therapeutic-license-agreement-8
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-19 14:34:20
                    [post_modified_gmt] => 2024-09-19 14:34:20
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5806
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [37] => WP_Post Object
                (
                    [ID] => 5280
                    [post_author] => 5
                    [post_date] => 2022-07-08 11:46:11
                    [post_date_gmt] => 2022-07-08 11:46:11
                    [post_content] => 
                    [post_title] => Shionogi – GARDP, Cefiderocol License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => shionogi-gardp-cefiderocol-license-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-23 12:07:46
                    [post_modified_gmt] => 2024-09-23 12:07:46
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5280
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [38] => WP_Post Object
                (
                    [ID] => 5122
                    [post_author] => 5
                    [post_date] => 2022-06-29 14:42:34
                    [post_date_gmt] => 2022-06-29 14:42:34
                    [post_content] => 
                    [post_title] => NIH – MPP (C-TAP), COVID-19 Technologies, Patent and Biological Material License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => 5122
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 14:03:18
                    [post_modified_gmt] => 2024-09-20 14:03:18
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=5122
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [39] => WP_Post Object
                (
                    [ID] => 4868
                    [post_author] => 5
                    [post_date] => 2022-06-07 09:30:21
                    [post_date_gmt] => 2022-06-07 09:30:21
                    [post_content] => 
                    [post_title] => Boston University Startup Exclusive License Template
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => boston-university-startup-exclusive-license-template-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-20 12:32:18
                    [post_modified_gmt] => 2023-06-20 12:32:18
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4868
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [40] => WP_Post Object
                (
                    [ID] => 4850
                    [post_author] => 5
                    [post_date] => 2022-05-31 10:27:15
                    [post_date_gmt] => 2022-05-31 10:27:15
                    [post_content] => 
                    [post_title] => Elkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => elkurt-ocean-biomedical-malaria-vaccine-exclusive-license-agreement-16
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-08 13:10:55
                    [post_modified_gmt] => 2024-04-08 13:10:55
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4850
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [41] => WP_Post Object
                (
                    [ID] => 4806
                    [post_author] => 5
                    [post_date] => 2022-05-24 08:59:08
                    [post_date_gmt] => 2022-05-24 08:59:08
                    [post_content] => 
                    [post_title] => CSIC - MPP (C-TAP), COVID-19 Diagnostic, Patent & Material License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => csic-mpp-covid-19-antibody-diagnostic-patent-material-license-agreement-9
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-27 10:11:24
                    [post_modified_gmt] => 2023-09-27 10:11:24
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4806
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [42] => WP_Post Object
                (
                    [ID] => 4490
                    [post_author] => 5
                    [post_date] => 2022-03-17 15:37:26
                    [post_date_gmt] => 2022-03-17 15:37:26
                    [post_content] => 
                    [post_title] => Cellscript – BioNTech mRNA Technology Patent Sublicense
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => cellscript-biontech-mrna-technology-patent-sublicense-11
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-06-21 09:05:15
                    [post_modified_gmt] => 2023-06-21 09:05:15
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4490
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [43] => WP_Post Object
                (
                    [ID] => 4079
                    [post_author] => 5
                    [post_date] => 2022-01-11 08:07:49
                    [post_date_gmt] => 2022-01-11 08:07:49
                    [post_content] => 
                    [post_title] => University of Washington – MPP, Long-acting Injectable HIV Treatment License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => university-of-washington-medicines-patent-pool-long-acting-injectable-hiv-treatment-license-agreement-6
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-04-12 12:51:06
                    [post_modified_gmt] => 2024-04-12 12:51:06
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4079
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [44] => WP_Post Object
                (
                    [ID] => 4051
                    [post_author] => 5
                    [post_date] => 2022-01-03 11:01:41
                    [post_date_gmt] => 2022-01-03 11:01:41
                    [post_content] => 
                    [post_title] => Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => ocugen-bbil-covid-19-vaccine-covaxin-co-development-supply-commercialization-agreement-17
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 14:25:43
                    [post_modified_gmt] => 2024-09-20 14:25:43
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4051
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [45] => WP_Post Object
                (
                    [ID] => 4009
                    [post_author] => 5
                    [post_date] => 2021-12-14 15:10:51
                    [post_date_gmt] => 2021-12-14 15:10:51
                    [post_content] => 
                    [post_title] => CureVac – GSK, COVID-19 Vaccine Collaboration and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => curevac-and-gsk-collaboration-and-license-agreement-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-09-27 11:47:52
                    [post_modified_gmt] => 2023-09-27 11:47:52
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=4009
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [46] => WP_Post Object
                (
                    [ID] => 3909
                    [post_author] => 5
                    [post_date] => 2021-11-22 13:29:28
                    [post_date_gmt] => 2021-11-22 13:29:28
                    [post_content] => 
                    [post_title] => Merck – MPP, Molnupiravir License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => msd-mpp-molnupiravir-license-agreement-17
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-09-20 08:09:59
                    [post_modified_gmt] => 2024-09-20 08:09:59
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=3909
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [47] => WP_Post Object
                (
                    [ID] => 3810
                    [post_author] => 5
                    [post_date] => 2021-09-10 12:21:33
                    [post_date_gmt] => 2021-09-10 12:21:33
                    [post_content] => 
                    [post_title] => Novavax - Serum Institute of India, COVID-19 Vaccine Supply and License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => novavax-serum-institute-of-india-covid-19-vaccine-supply-and-license-agreement-15
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-07-10 14:55:36
                    [post_modified_gmt] => 2023-07-10 14:55:36
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=3810
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

            [48] => WP_Post Object
                (
                    [ID] => 3418
                    [post_author] => 5
                    [post_date] => 2021-06-30 19:06:19
                    [post_date_gmt] => 2021-06-30 19:06:19
                    [post_content] => 
                    [post_title] => NIH – GeoVax, Non-Exclusive Patent and Biological Materials License Agreement
                    [post_excerpt] => 
                    [post_status] => publish
                    [comment_status] => closed
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => nih-geovax-non-exclusive-patent-and-biological-materials-license-agreement-12
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2023-08-30 15:19:00
                    [post_modified_gmt] => 2023-08-30 15:19:00
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://ghiaa.org/?post_type=provision_document&p=3418
                    [menu_order] => 0
                    [post_type] => provision_document
                    [post_mime_type] => 
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [invalid_get] => 
    [is_text_search] => 
    [has_agreement_filters] => 1
    [has_any_agreement_filter] => Array
        (
            [agreement-type] => 
        )

    [found_agreements] => 1
    [has_provision_filters] => 1
    [found_provisions] => 1
    [lbl_quick_search:GHIAA2019\MapguideSearch:private] => Search results for:
    [lbl_issue:GHIAA2019\MapguideSearch:private] => Issue:
    [lbl_key_term:GHIAA2019\MapguideSearch:private] => Key Term:
    [lbl_agreement_type:GHIAA2019\MapguideSearch:private] => Agreement Type:
    [lbl_partner_type:GHIAA2019\MapguideSearch:private] => Partner Type:
    [lbl_technology:GHIAA2019\MapguideSearch:private] => Technology:
    [lbl_development_stage:GHIAA2019\MapguideSearch:private] => Development Stage:
    [issues_by_id:GHIAA2019\MapguideSearch:private] => Array
        (
            [101] => WP_Term Object
                (
                    [term_id] => 101
                    [name] => Access plans & principles
                    [slug] => equitable-access
                    [term_group] => 0
                    [term_taxonomy_id] => 101
                    [taxonomy] => issue
                    [description] => 
 	How should equitable or global access be defined?
 	Should the developer be required to comply with an equitable access policy?
 	Should the developer be required to establish an access plan?

                    [parent] => 46
                    [count] => 64
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [100] => WP_Term Object
                (
                    [term_id] => 100
                    [name] => Affordable pricing
                    [slug] => pricing
                    [term_group] => 0
                    [term_taxonomy_id] => 100
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 46
                    [count] => 57
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [66] => WP_Term Object
                (
                    [term_id] => 66
                    [name] => Benefit sharing
                    [slug] => benefit-revenue-sharing
                    [term_group] => 0
                    [term_taxonomy_id] => 66
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 19
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [53] => WP_Term Object
                (
                    [term_id] => 53
                    [name] => Business model
                    [slug] => business-model
                    [term_group] => 0
                    [term_taxonomy_id] => 53
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [371] => WP_Term Object
                (
                    [term_id] => 371
                    [name] => Clinical trial conduct
                    [slug] => clinical-trial-conduct
                    [term_group] => 0
                    [term_taxonomy_id] => 371
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 16
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [84] => WP_Term Object
                (
                    [term_id] => 84
                    [name] => Confidentiality
                    [slug] => confidentiality
                    [term_group] => 0
                    [term_taxonomy_id] => 84
                    [taxonomy] => issue
                    [description] => 
 	What is the scope of confidential information?
 	What are the obligations of the parties to protect confidential information?
 	Are there any exceptions to the confidentiality obligations?
 	Are the parties permitted to make public announcements related to the project?
 	Can the parties use each other’s name and logo for general marketing materials?

                    [parent] => 49
                    [count] => 123
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [271] => WP_Term Object
                (
                    [term_id] => 271
                    [name] => Donation
                    [slug] => donation
                    [term_group] => 0
                    [term_taxonomy_id] => 271
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 46
                    [count] => 5
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [72] => WP_Term Object
                (
                    [term_id] => 72
                    [name] => Effects of termination
                    [slug] => effect-of-termination
                    [term_group] => 0
                    [term_taxonomy_id] => 72
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 52
                    [count] => 106
                    [filter] => raw
                    [parent_name] => Term & termination
                    [parent_slug] => term-and-termination
                )

            [281] => WP_Term Object
                (
                    [term_id] => 281
                    [name] => Ensuring continuity
                    [slug] => ensuring-continuity
                    [term_group] => 0
                    [term_taxonomy_id] => 281
                    [taxonomy] => issue
                    [description] => 
 	Under what circumstances can the continuity rights be exercised? (What are the conditions precedent?)
 	What is an appropriate scope for the continuity rights? What are the rights and obligations of each party?
 	Should related license grants vest upon execution of the agreement, or at a later stage in development?
 	Should there be an escrow requirement?
 	Should there be any restrictions on the developer’s ability to transfer project-related intellectual property to a third party?

                    [parent] => 46
                    [count] => 64
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [46] => WP_Term Object
                (
                    [term_id] => 46
                    [name] => Equitable access
                    [slug] => access-to-medicines
                    [term_group] => 0
                    [term_taxonomy_id] => 46
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [278] => WP_Term Object
                (
                    [term_id] => 278
                    [name] => Governance
                    [slug] => roles-responsibilities
                    [term_group] => 0
                    [term_taxonomy_id] => 278
                    [taxonomy] => issue
                    [description] => 
 	Do the parties govern the project through a joint steering committee ("JSC")? If so, what are the parties expressly designated roles and responsibilities with respect to the JSC?
 	Are there other committees, important governance bodies, or designated individual positions? What are the parties' roles and responsibilities with respect to them?
 	Are the parties required to meet in accordance with a defined schedule for decision-making and progress reporting activities?
 	What are the resolution mechanisms for disputes related to the agreement?
 	Are there any requirements for policies or procedures to manage potential conflicts of interest?

                    [parent] => 53
                    [count] => 109
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [80] => WP_Term Object
                (
                    [term_id] => 80
                    [name] => Indemnification & liability
                    [slug] => indemnity
                    [term_group] => 0
                    [term_taxonomy_id] => 80
                    [taxonomy] => issue
                    [description] => 
 	What occurrences could result in a liability claim against which one party will indemnify the other?
 	Are there any circumstances under which one party will not indemnify the other?
 	What is the process for managing liability claims?
 	Are there government or other types of indemnification schemes?
 	Is there any limitation or monetary cap on each party’s liabilities under the agreement?

                    [parent] => 50
                    [count] => 120
                    [filter] => raw
                    [parent_name] => Liability
                    [parent_slug] => liability
                )

            [257] => WP_Term Object
                (
                    [term_id] => 257
                    [name] => Information sharing
                    [slug] => information-sharing-information-sharing
                    [term_group] => 0
                    [term_taxonomy_id] => 257
                    [taxonomy] => issue
                    [description] => 
 	What financial and project progress information must be shared between the parties?
 	What is the required timeline for sharing information?
 	How is the receiving party permitted to use the information received?
 	Do the parties have the right to verify the information reported?

                    [parent] => 49
                    [count] => 114
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [109] => WP_Term Object
                (
                    [term_id] => 109
                    [name] => Insurance
                    [slug] => insurance
                    [term_group] => 0
                    [term_taxonomy_id] => 109
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 50
                    [count] => 76
                    [filter] => raw
                    [parent_name] => Liability
                    [parent_slug] => liability
                )

            [48] => WP_Term Object
                (
                    [term_id] => 48
                    [name] => Intellectual property
                    [slug] => ip-ownership
                    [term_group] => 0
                    [term_taxonomy_id] => 48
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [50] => WP_Term Object
                (
                    [term_id] => 50
                    [name] => Liability
                    [slug] => liability
                    [term_group] => 0
                    [term_taxonomy_id] => 50
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [88] => WP_Term Object
                (
                    [term_id] => 88
                    [name] => License grants
                    [slug] => license-grants
                    [term_group] => 0
                    [term_taxonomy_id] => 88
                    [taxonomy] => issue
                    [description] => 
 	Are any licenses granted for the use of background or foreground intellectual property?
 	What is the scope of the licensed intellectual property?
 	What is the territory of the license?
 	Is the license exclusive or non-exclusive?
 	Are there any restrictions on the use of the licensed intellectual property?
 	Are there any specific obligations to exploit the licensed intellectual property?
 	Can the licensee grant sublicenses to third parties?
 	Will products manufactured under license be marketed as branded or generic? (i.e. will they bear the licensor’s trademarks/trade dress)

                    [parent] => 48
                    [count] => 115
                    [filter] => raw
                    [parent_name] => Intellectual property
                    [parent_slug] => ip-ownership
                )

            [87] => WP_Term Object
                (
                    [term_id] => 87
                    [name] => Ownership of IP
                    [slug] => ownership-ip
                    [term_group] => 0
                    [term_taxonomy_id] => 87
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 48
                    [count] => 87
                    [filter] => raw
                    [parent_name] => Intellectual property
                    [parent_slug] => ip-ownership
                )

            [70] => WP_Term Object
                (
                    [term_id] => 70
                    [name] => Payment structures
                    [slug] => royalties-and-payments
                    [term_group] => 0
                    [term_taxonomy_id] => 70
                    [taxonomy] => issue
                    [description] => What is the payment structure under this agreement? 
What are the mechanisms to limit exposure to additional payments or expenses?
                    [parent] => 53
                    [count] => 98
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [102] => WP_Term Object
                (
                    [term_id] => 102
                    [name] => Preparedness & response
                    [slug] => outbreak-preparedness
                    [term_group] => 0
                    [term_taxonomy_id] => 102
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 46
                    [count] => 16
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [268] => WP_Term Object
                (
                    [term_id] => 268
                    [name] => Product supply
                    [slug] => supply-purchase-of-products
                    [term_group] => 0
                    [term_taxonomy_id] => 268
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 47
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [49] => WP_Term Object
                (
                    [term_id] => 49
                    [name] => Protecting & sharing information
                    [slug] => information-sharing
                    [term_group] => 0
                    [term_taxonomy_id] => 49
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [90] => WP_Term Object
                (
                    [term_id] => 90
                    [name] => Protection of IP
                    [slug] => protection-results
                    [term_group] => 0
                    [term_taxonomy_id] => 90
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 48
                    [count] => 91
                    [filter] => raw
                    [parent_name] => Intellectual property
                    [parent_slug] => ip-ownership
                )

            [290] => WP_Term Object
                (
                    [term_id] => 290
                    [name] => Publication of results
                    [slug] => publication-of-results
                    [term_group] => 0
                    [term_taxonomy_id] => 290
                    [taxonomy] => issue
                    [description] => What information are the parties required or permitted to publish?
What is the required timeline for making data available?
What are the acceptable publication channels?
Is compliance with a specific open access policy required?
                    [parent] => 49
                    [count] => 72
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [372] => WP_Term Object
                (
                    [term_id] => 372
                    [name] => Quality management
                    [slug] => quality-management
                    [term_group] => 0
                    [term_taxonomy_id] => 372
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 47
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [56] => WP_Term Object
                (
                    [term_id] => 56
                    [name] => Regulatory strategy
                    [slug] => regulatory-strategy
                    [term_group] => 0
                    [term_taxonomy_id] => 56
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 62
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [81] => WP_Term Object
                (
                    [term_id] => 81
                    [name] => Representations & warranties
                    [slug] => warranties
                    [term_group] => 0
                    [term_taxonomy_id] => 81
                    [taxonomy] => issue
                    [description] => Should the parties make any warranties, and if so, what is the scope?
                    [parent] => 50
                    [count] => 108
                    [filter] => raw
                    [parent_name] => Liability
                    [parent_slug] => liability
                )

            [86] => WP_Term Object
                (
                    [term_id] => 86
                    [name] => Technology transfer
                    [slug] => technology-transfer
                    [term_group] => 0
                    [term_taxonomy_id] => 86
                    [taxonomy] => issue
                    [description] => What is included in the technology and/or materials to be transferred?
What are the responsibilities of each party to in relation to the transfer of materials and/or technology?
                    [parent] => 49
                    [count] => 49
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [52] => WP_Term Object
                (
                    [term_id] => 52
                    [name] => Term & termination
                    [slug] => term-and-termination
                    [term_group] => 0
                    [term_taxonomy_id] => 52
                    [taxonomy] => issue
                    [description] => Term

 	What is the term of the agreement? Is it tied to the timeline of the project or license grants?

Termination

 	Under what circumstances may a party terminate or withdraw from the agreement?

Effects of Termination

 	What are the effects of termination or withdrawal by a party?

                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [76] => WP_Term Object
                (
                    [term_id] => 76
                    [name] => Term of agreement
                    [slug] => term-of-agreement
                    [term_group] => 0
                    [term_taxonomy_id] => 76
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 52
                    [count] => 107
                    [filter] => raw
                    [parent_name] => Term & termination
                    [parent_slug] => term-and-termination
                )

            [74] => WP_Term Object
                (
                    [term_id] => 74
                    [name] => Termination & withdrawal
                    [slug] => termination-and-withdrawal
                    [term_group] => 0
                    [term_taxonomy_id] => 74
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 52
                    [count] => 112
                    [filter] => raw
                    [parent_name] => Term & termination
                    [parent_slug] => term-and-termination
                )

            [282] => WP_Term Object
                (
                    [term_id] => 282
                    [name] => Territory access commitments
                    [slug] => territory-access-commitments
                    [term_group] => 0
                    [term_taxonomy_id] => 282
                    [taxonomy] => issue
                    [description] => 
 	How should ‘territory’ be defined under the agreement? Should the definition make a distinction between different types of purchaser (e.g. public sector vs. private sector)?
 	Should the developer be required to apply for regulatory approval in priority access markets?
 	Should the developer be required to commit a proportion of the product manufactured to a certain country or purchasing organization?
 	Should the developer be required to identify a third party that could fulfill supply requirements for the access territories in the event that the developer does not?
 	Should the agreement include any anti-diversion provisions?

                    [parent] => 46
                    [count] => 69
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

        )

    [issues_by_slug:GHIAA2019\MapguideSearch:private] => Array
        (
            [equitable-access] => WP_Term Object
                (
                    [term_id] => 101
                    [name] => Access plans & principles
                    [slug] => equitable-access
                    [term_group] => 0
                    [term_taxonomy_id] => 101
                    [taxonomy] => issue
                    [description] => 
 	How should equitable or global access be defined?
 	Should the developer be required to comply with an equitable access policy?
 	Should the developer be required to establish an access plan?

                    [parent] => 46
                    [count] => 64
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [pricing] => WP_Term Object
                (
                    [term_id] => 100
                    [name] => Affordable pricing
                    [slug] => pricing
                    [term_group] => 0
                    [term_taxonomy_id] => 100
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 46
                    [count] => 57
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [benefit-revenue-sharing] => WP_Term Object
                (
                    [term_id] => 66
                    [name] => Benefit sharing
                    [slug] => benefit-revenue-sharing
                    [term_group] => 0
                    [term_taxonomy_id] => 66
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 19
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [business-model] => WP_Term Object
                (
                    [term_id] => 53
                    [name] => Business model
                    [slug] => business-model
                    [term_group] => 0
                    [term_taxonomy_id] => 53
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [clinical-trial-conduct] => WP_Term Object
                (
                    [term_id] => 371
                    [name] => Clinical trial conduct
                    [slug] => clinical-trial-conduct
                    [term_group] => 0
                    [term_taxonomy_id] => 371
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 16
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [confidentiality] => WP_Term Object
                (
                    [term_id] => 84
                    [name] => Confidentiality
                    [slug] => confidentiality
                    [term_group] => 0
                    [term_taxonomy_id] => 84
                    [taxonomy] => issue
                    [description] => 
 	What is the scope of confidential information?
 	What are the obligations of the parties to protect confidential information?
 	Are there any exceptions to the confidentiality obligations?
 	Are the parties permitted to make public announcements related to the project?
 	Can the parties use each other’s name and logo for general marketing materials?

                    [parent] => 49
                    [count] => 123
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [donation] => WP_Term Object
                (
                    [term_id] => 271
                    [name] => Donation
                    [slug] => donation
                    [term_group] => 0
                    [term_taxonomy_id] => 271
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 46
                    [count] => 5
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [effect-of-termination] => WP_Term Object
                (
                    [term_id] => 72
                    [name] => Effects of termination
                    [slug] => effect-of-termination
                    [term_group] => 0
                    [term_taxonomy_id] => 72
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 52
                    [count] => 106
                    [filter] => raw
                    [parent_name] => Term & termination
                    [parent_slug] => term-and-termination
                )

            [ensuring-continuity] => WP_Term Object
                (
                    [term_id] => 281
                    [name] => Ensuring continuity
                    [slug] => ensuring-continuity
                    [term_group] => 0
                    [term_taxonomy_id] => 281
                    [taxonomy] => issue
                    [description] => 
 	Under what circumstances can the continuity rights be exercised? (What are the conditions precedent?)
 	What is an appropriate scope for the continuity rights? What are the rights and obligations of each party?
 	Should related license grants vest upon execution of the agreement, or at a later stage in development?
 	Should there be an escrow requirement?
 	Should there be any restrictions on the developer’s ability to transfer project-related intellectual property to a third party?

                    [parent] => 46
                    [count] => 64
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [access-to-medicines] => WP_Term Object
                (
                    [term_id] => 46
                    [name] => Equitable access
                    [slug] => access-to-medicines
                    [term_group] => 0
                    [term_taxonomy_id] => 46
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [roles-responsibilities] => WP_Term Object
                (
                    [term_id] => 278
                    [name] => Governance
                    [slug] => roles-responsibilities
                    [term_group] => 0
                    [term_taxonomy_id] => 278
                    [taxonomy] => issue
                    [description] => 
 	Do the parties govern the project through a joint steering committee ("JSC")? If so, what are the parties expressly designated roles and responsibilities with respect to the JSC?
 	Are there other committees, important governance bodies, or designated individual positions? What are the parties' roles and responsibilities with respect to them?
 	Are the parties required to meet in accordance with a defined schedule for decision-making and progress reporting activities?
 	What are the resolution mechanisms for disputes related to the agreement?
 	Are there any requirements for policies or procedures to manage potential conflicts of interest?

                    [parent] => 53
                    [count] => 109
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [indemnity] => WP_Term Object
                (
                    [term_id] => 80
                    [name] => Indemnification & liability
                    [slug] => indemnity
                    [term_group] => 0
                    [term_taxonomy_id] => 80
                    [taxonomy] => issue
                    [description] => 
 	What occurrences could result in a liability claim against which one party will indemnify the other?
 	Are there any circumstances under which one party will not indemnify the other?
 	What is the process for managing liability claims?
 	Are there government or other types of indemnification schemes?
 	Is there any limitation or monetary cap on each party’s liabilities under the agreement?

                    [parent] => 50
                    [count] => 120
                    [filter] => raw
                    [parent_name] => Liability
                    [parent_slug] => liability
                )

            [information-sharing-information-sharing] => WP_Term Object
                (
                    [term_id] => 257
                    [name] => Information sharing
                    [slug] => information-sharing-information-sharing
                    [term_group] => 0
                    [term_taxonomy_id] => 257
                    [taxonomy] => issue
                    [description] => 
 	What financial and project progress information must be shared between the parties?
 	What is the required timeline for sharing information?
 	How is the receiving party permitted to use the information received?
 	Do the parties have the right to verify the information reported?

                    [parent] => 49
                    [count] => 114
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [insurance] => WP_Term Object
                (
                    [term_id] => 109
                    [name] => Insurance
                    [slug] => insurance
                    [term_group] => 0
                    [term_taxonomy_id] => 109
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 50
                    [count] => 76
                    [filter] => raw
                    [parent_name] => Liability
                    [parent_slug] => liability
                )

            [ip-ownership] => WP_Term Object
                (
                    [term_id] => 48
                    [name] => Intellectual property
                    [slug] => ip-ownership
                    [term_group] => 0
                    [term_taxonomy_id] => 48
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [liability] => WP_Term Object
                (
                    [term_id] => 50
                    [name] => Liability
                    [slug] => liability
                    [term_group] => 0
                    [term_taxonomy_id] => 50
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [license-grants] => WP_Term Object
                (
                    [term_id] => 88
                    [name] => License grants
                    [slug] => license-grants
                    [term_group] => 0
                    [term_taxonomy_id] => 88
                    [taxonomy] => issue
                    [description] => 
 	Are any licenses granted for the use of background or foreground intellectual property?
 	What is the scope of the licensed intellectual property?
 	What is the territory of the license?
 	Is the license exclusive or non-exclusive?
 	Are there any restrictions on the use of the licensed intellectual property?
 	Are there any specific obligations to exploit the licensed intellectual property?
 	Can the licensee grant sublicenses to third parties?
 	Will products manufactured under license be marketed as branded or generic? (i.e. will they bear the licensor’s trademarks/trade dress)

                    [parent] => 48
                    [count] => 115
                    [filter] => raw
                    [parent_name] => Intellectual property
                    [parent_slug] => ip-ownership
                )

            [ownership-ip] => WP_Term Object
                (
                    [term_id] => 87
                    [name] => Ownership of IP
                    [slug] => ownership-ip
                    [term_group] => 0
                    [term_taxonomy_id] => 87
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 48
                    [count] => 87
                    [filter] => raw
                    [parent_name] => Intellectual property
                    [parent_slug] => ip-ownership
                )

            [royalties-and-payments] => WP_Term Object
                (
                    [term_id] => 70
                    [name] => Payment structures
                    [slug] => royalties-and-payments
                    [term_group] => 0
                    [term_taxonomy_id] => 70
                    [taxonomy] => issue
                    [description] => What is the payment structure under this agreement? 
What are the mechanisms to limit exposure to additional payments or expenses?
                    [parent] => 53
                    [count] => 98
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [outbreak-preparedness] => WP_Term Object
                (
                    [term_id] => 102
                    [name] => Preparedness & response
                    [slug] => outbreak-preparedness
                    [term_group] => 0
                    [term_taxonomy_id] => 102
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 46
                    [count] => 16
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

            [supply-purchase-of-products] => WP_Term Object
                (
                    [term_id] => 268
                    [name] => Product supply
                    [slug] => supply-purchase-of-products
                    [term_group] => 0
                    [term_taxonomy_id] => 268
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 47
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [information-sharing] => WP_Term Object
                (
                    [term_id] => 49
                    [name] => Protecting & sharing information
                    [slug] => information-sharing
                    [term_group] => 0
                    [term_taxonomy_id] => 49
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [protection-results] => WP_Term Object
                (
                    [term_id] => 90
                    [name] => Protection of IP
                    [slug] => protection-results
                    [term_group] => 0
                    [term_taxonomy_id] => 90
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 48
                    [count] => 91
                    [filter] => raw
                    [parent_name] => Intellectual property
                    [parent_slug] => ip-ownership
                )

            [publication-of-results] => WP_Term Object
                (
                    [term_id] => 290
                    [name] => Publication of results
                    [slug] => publication-of-results
                    [term_group] => 0
                    [term_taxonomy_id] => 290
                    [taxonomy] => issue
                    [description] => What information are the parties required or permitted to publish?
What is the required timeline for making data available?
What are the acceptable publication channels?
Is compliance with a specific open access policy required?
                    [parent] => 49
                    [count] => 72
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [quality-management] => WP_Term Object
                (
                    [term_id] => 372
                    [name] => Quality management
                    [slug] => quality-management
                    [term_group] => 0
                    [term_taxonomy_id] => 372
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 47
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [regulatory-strategy] => WP_Term Object
                (
                    [term_id] => 56
                    [name] => Regulatory strategy
                    [slug] => regulatory-strategy
                    [term_group] => 0
                    [term_taxonomy_id] => 56
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 53
                    [count] => 62
                    [filter] => raw
                    [parent_name] => Business model
                    [parent_slug] => business-model
                )

            [warranties] => WP_Term Object
                (
                    [term_id] => 81
                    [name] => Representations & warranties
                    [slug] => warranties
                    [term_group] => 0
                    [term_taxonomy_id] => 81
                    [taxonomy] => issue
                    [description] => Should the parties make any warranties, and if so, what is the scope?
                    [parent] => 50
                    [count] => 108
                    [filter] => raw
                    [parent_name] => Liability
                    [parent_slug] => liability
                )

            [technology-transfer] => WP_Term Object
                (
                    [term_id] => 86
                    [name] => Technology transfer
                    [slug] => technology-transfer
                    [term_group] => 0
                    [term_taxonomy_id] => 86
                    [taxonomy] => issue
                    [description] => What is included in the technology and/or materials to be transferred?
What are the responsibilities of each party to in relation to the transfer of materials and/or technology?
                    [parent] => 49
                    [count] => 49
                    [filter] => raw
                    [parent_name] => Protecting & sharing information
                    [parent_slug] => information-sharing
                )

            [term-and-termination] => WP_Term Object
                (
                    [term_id] => 52
                    [name] => Term & termination
                    [slug] => term-and-termination
                    [term_group] => 0
                    [term_taxonomy_id] => 52
                    [taxonomy] => issue
                    [description] => Term

 	What is the term of the agreement? Is it tied to the timeline of the project or license grants?

Termination

 	Under what circumstances may a party terminate or withdraw from the agreement?

Effects of Termination

 	What are the effects of termination or withdrawal by a party?

                    [parent] => 0
                    [count] => 0
                    [filter] => raw
                    [parent_name] => 
                    [parent_slug] => 
                )

            [term-of-agreement] => WP_Term Object
                (
                    [term_id] => 76
                    [name] => Term of agreement
                    [slug] => term-of-agreement
                    [term_group] => 0
                    [term_taxonomy_id] => 76
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 52
                    [count] => 107
                    [filter] => raw
                    [parent_name] => Term & termination
                    [parent_slug] => term-and-termination
                )

            [termination-and-withdrawal] => WP_Term Object
                (
                    [term_id] => 74
                    [name] => Termination & withdrawal
                    [slug] => termination-and-withdrawal
                    [term_group] => 0
                    [term_taxonomy_id] => 74
                    [taxonomy] => issue
                    [description] => 
                    [parent] => 52
                    [count] => 112
                    [filter] => raw
                    [parent_name] => Term & termination
                    [parent_slug] => term-and-termination
                )

            [territory-access-commitments] => WP_Term Object
                (
                    [term_id] => 282
                    [name] => Territory access commitments
                    [slug] => territory-access-commitments
                    [term_group] => 0
                    [term_taxonomy_id] => 282
                    [taxonomy] => issue
                    [description] => 
 	How should ‘territory’ be defined under the agreement? Should the definition make a distinction between different types of purchaser (e.g. public sector vs. private sector)?
 	Should the developer be required to apply for regulatory approval in priority access markets?
 	Should the developer be required to commit a proportion of the product manufactured to a certain country or purchasing organization?
 	Should the developer be required to identify a third party that could fulfill supply requirements for the access territories in the event that the developer does not?
 	Should the agreement include any anti-diversion provisions?

                    [parent] => 46
                    [count] => 69
                    [filter] => raw
                    [parent_name] => Equitable access
                    [parent_slug] => access-to-medicines
                )

        )

    [filter_issues:GHIAA2019\MapguideSearch:private] => Array
        (
            [0] => roles-responsibilities
        )

)